<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id>
<journal-title-group>
<journal-title>PLOS Computational Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1005368</article-id>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-16-01469</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Hepacivirus</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Hepacivirus</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Hepacivirus</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>Hepacivirus</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hepatitis viruses</subject><subj-group><subject>Hepatitis C virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogenesis</subject><subj-group><subject>Host-pathogen interactions</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Protein complexes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and information sciences</subject><subj-group><subject>Network analysis</subject><subj-group><subject>Protein interaction networks</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteomics</subject><subj-group><subject>Protein interaction networks</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Biological databases</subject><subj-group><subject>Sequence databases</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence analysis</subject><subj-group><subject>Sequence databases</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Protein domains</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Carcinogenesis</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs</article-title>
<alt-title alt-title-type="running-head">Host Factors of HCV Entry</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6514-5612</contrib-id>
<name name-style="western">
<surname>Chiang</surname>
<given-names>Austin W. T.</given-names>
</name>
<xref ref-type="fn" rid="currentaff001"><sup>¤a</sup></xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Walt Y. L.</given-names>
</name>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="fn" rid="currentaff002"><sup>¤b</sup></xref>
<xref ref-type="fn" rid="currentaff003"><sup>¤c</sup></xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9657-5663</contrib-id>
<name name-style="western">
<surname>Hwang</surname>
<given-names>Ming-Jing</given-names>
</name>
<xref ref-type="corresp" rid="cor001">*</xref>
<xref ref-type="aff" rid="aff001"/>
</contrib>
</contrib-group>
<aff id="aff001"><addr-line>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Wilke</surname>
<given-names>Claus O.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Texas at Austin, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> TW MJH.</p></list-item> <list-item><p><bold>Data curation:</bold> TW AWTC WYLW.</p></list-item> <list-item><p><bold>Formal analysis:</bold> TW AWTC WYLW MJH.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> MJH.</p></list-item> <list-item><p><bold>Investigation:</bold> TW AWTC WYLW.</p></list-item> <list-item><p><bold>Methodology:</bold> AWTC TW WYLW.</p></list-item> <list-item><p><bold>Project administration:</bold> MJH.</p></list-item> <list-item><p><bold>Resources:</bold> MJH.</p></list-item> <list-item><p><bold>Supervision:</bold> MJH.</p></list-item> <list-item><p><bold>Validation:</bold> AWTC TW WYLW.</p></list-item> <list-item><p><bold>Visualization:</bold> AWTC WYLW.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> AWTC WYLW TW.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> AWTC WYLW MJH.</p></list-item></list>
</p>
</fn>
<fn fn-type="current-aff" id="currentaff001">
<label>¤a</label><p>Current address: Department of Pediatrics, University of California, San Diego, CA, United States of America</p>
</fn>
<fn fn-type="current-aff" id="currentaff002">
<label>¤b</label><p>Current address: Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program (TIGP), Academia Sinica, Taipei, Taiwan</p>
</fn>
<fn fn-type="current-aff" id="currentaff003">
<label>¤c</label><p>Current address: Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taipei, Taiwan</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">mjhwang@ibms.sinica.edu.tw</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<elocation-id>e1005368</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Chiang et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pcbi.1005368"/>
<abstract>
<p>Host factors that facilitate viral entry into cells can, in principle, be identified from a virus-host protein interaction network, but for most viruses information for such a network is limited. To help fill this void, we developed a bioinformatics approach and applied it to hepatitis C virus (HCV) infection, which is a current concern for global health. Using this approach, we identified short linear sequence motifs, conserved in the envelope proteins of HCV (E1/E2), that potentially can bind human proteins present on the surface of hepatocytes so as to construct an HCV (envelope)-host protein interaction network. Gene Ontology functional and KEGG pathway analyses showed that the identified host proteins are enriched in cell entry and carcinogenesis functionalities. The validity of our results is supported by much published experimental data. Our general approach should be useful when developing antiviral agents, particularly those that target virus-host interactions.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>Viruses recruit host proteins, called entry factors, to help gain entry to host cells. Identification of entry factors can provide targets for developing antiviral drugs. By exploring the concept that short linear peptide motifs involved in human protein-protein interactions may be mimicked by viruses to hijack certain host cellular processes and thereby assist viral infection/survival, we developed a bioinformatics strategy to computationally identify entry factors of hepatitis C virus (HCV) infection, which is a worldwide health problem. Analysis of cellular functions and biochemical pathways indicated that the human proteins we identified usually play a role in cell entry and/or carcinogenesis, and results of the analysis are generally supported by experimental studies on HCV infection, including the ~80% (15 of 19) prediction rate of known HCV hepatocyte entry factors. Because molecular mimicry is a general concept, our bioinformatics strategy is a timely approach to identify new targets for antiviral research, not only for HCV but also for other viruses.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004663</institution-id>
<institution>Ministry of Science and Technology, Taiwan</institution>
</institution-wrap>
</funding-source>
<award-id>MOST 104-2811-B-001-004</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9657-5663</contrib-id>
<name name-style="western">
<surname>Hwang</surname>
<given-names>Ming-Jing</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was funded by the Ministry of Science and Technology, Taiwan (<ext-link ext-link-type="uri" xlink:href="https://www.most.gov.tw/" xlink:type="simple">https://www.most.gov.tw/</ext-link>), under grant number MOST 104-2811-B-001-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<page-count count="24"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2017-02-10</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The conventional approach to countering viral infections has been to develop drugs that target viral genetic material or proteins. However, two major roadblocks to this strategy exist: 1) the limited number of druggable viral proteins owing to small viral genomes, and 2) drug resistance that occurs on a relatively short time scale owing to substantial viral genomic mutation rates. To circumvent these problems, over the past decade antiviral drug development has shifted from targeting viral proteins to host proteins that interact with components of the virus [<xref ref-type="bibr" rid="pcbi.1005368.ref001">1</xref>]. For example, compounds that inhibit interactions between viral and human proteins have been identified [<xref ref-type="bibr" rid="pcbi.1005368.ref002">2</xref>], including the compound LEDGIN, which targets the interaction between HIV integrase and human transcriptional coactivator p75 [<xref ref-type="bibr" rid="pcbi.1005368.ref003">3</xref>]. Cell-based genomic and proteomic assays that screen for host targets that interact with viral proteins have also been reported [<xref ref-type="bibr" rid="pcbi.1005368.ref004">4</xref>–<xref ref-type="bibr" rid="pcbi.1005368.ref006">6</xref>]. Nevertheless, given the large amount of biological data that has been accumulated from high-throughput omics-type experiments, development of a bioinformatics-sleuthing strategy that identifies potential antiviral host targets to complement experimental screens should be of considerable merit.</p>
<p>Herein, we describe the development of and evaluate such a bioinformatics strategy, the premise of which is based on viral “molecular mimicry,” an ability that viruses have developed over millions of years of evolution to antagonize their hosts [<xref ref-type="bibr" rid="pcbi.1005368.ref007">7</xref>]. Specifically, regions in viral proteins apparently can mimic short amino acid sequences found in human proteins involved in normal host protein-protein interactions (PPIs), so that a virus can hijack the PPI for its own purposes, such as hijacking a cellular process(es) to create the cell context needed for infection [<xref ref-type="bibr" rid="pcbi.1005368.ref008">8</xref>]. Consistent with this viral strategy, their proteins often contain host-like SLiMs (Short Linear Motifs) allowing them to interact with complementary host proteins [<xref ref-type="bibr" rid="pcbi.1005368.ref009">9</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref010">10</xref>]. Viral SLiMs can be identified by sequence comparison with those with the ability to bind eukaryotic protein domains as catalogued in the database ELM (Eukaryotic Linear Motif) [<xref ref-type="bibr" rid="pcbi.1005368.ref011">11</xref>]. The viral SLiMs, the host proteins that contain a matched SLiM-binding domain, and these proteins’ interacting partners in the human PPI network then form a putative virus-host interaction network, which can be integrated with known functional and network properties of cellular pathways, including those involved in disease states, thereby allowing identification of host factors whose native functions may be altered or hijacked by the virus to facilitate its infection and/or another of its life cycle stages.</p>
<p>To examine this molecular mimicry strategy and the feasibility of using human PPI network data to complement experimental studies, we focused on the hepatitis C virus (HCV) envelope proteins, E1 and E2, for the following reasons: First, HCV infection is a major health problem worldwide [<xref ref-type="bibr" rid="pcbi.1005368.ref012">12</xref>], and HCV E1 and E2 are known to play essential roles in HCV entry into human hepatocytes [<xref ref-type="bibr" rid="pcbi.1005368.ref013">13</xref>]; investigating E1 and E2 might therefore lead us to identify novel HCV entry factors as targets for drug design—an important step toward developing more effective anti-HCV drugs. Second, the complexity of the network and functional analysis required was significantly reduced because only liver cell surface proteins of the human proteome need to be considered. Third, many HCV entry–facilitating human proteins have been identified, which allowed us to compare <italic>in silico</italic> predictions with published experimental data.</p>
<p>Using the HCV E1 and E2 sequences as examples, <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1</xref> schematically depicts the four main components of our approach, which are detailed in Methods. First, conserved E1/E2 sequences from various HCV strains are identified that correspond to SLiMs found in the eukaryotic linear motif (ELM) database (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1A</xref>). Next, proteins on the surface of human hepatocytes known to bind such SLiMs are identified (they are called VIPs<sub>direct</sub> for Virus-Interacting host Proteins), as are host proteins (VIPs<sub>indirect</sub>) that bind VIPs<sub>direct</sub> (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>). Taking the experimentally determined interactions between VIPs<sub>direct</sub> and VIPs<sub>indirect</sub> from the original human PPI network ([<xref ref-type="bibr" rid="pcbi.1005368.ref014">14</xref>]; see <xref ref-type="sec" rid="sec011">Methods</xref>), a virus-host PPI network is then extracted that is constructed of the viral SLiMs and human VIPs (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B and 1C</xref>). This network contains modules (communities) of functionally related host proteins (nodes) and links (PPIs) within and between the modules connecting interacting nodes (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1C</xref>). Finally, a map connecting SLiMs to known antiviral peptides (AVPs) and complexes containing multiple (≥3) SLiM-interacting proteins is produced (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1D</xref>), for which statistical analyses are carried out to find enriched functionalities and pathways that correlate with published experimental data.</p>
<fig id="pcbi.1005368.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g001</object-id>
<label>Fig 1</label>
<caption>
<title>The four components of our bioinformatics strategy.</title>
<p><bold>(A)</bold> Identify human-type short linear motifs (SLiMs) found in a viral protein(s). <bold>(B)</bold> Construct a virus-host-PPI network. <bold>(C)</bold> Identify network modules and roles of the network nodes. <bold>(D)</bold> Build a map of AVP/SLiM-protein complexes. In parentheses are the numbers of motifs, proteins, modules, pathways, etc., identified in this study (see <xref ref-type="sec" rid="sec011">Methods</xref> for details).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g001" xlink:type="simple"/>
</fig>
<p>As shown below, the results show that the proteins we identified as possible hepatitis C virus (HCV) entry factors: 1) have a statistically significant propensity to be found in the PHISTO and EHCO lists, which contain experimentally identified HCV-interacting proteins and genes differentially expressed in HCV-induced hepatocellular carcinoma, respectively [<xref ref-type="bibr" rid="pcbi.1005368.ref015">15</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref016">16</xref>]; 2) have greater coverage of known HCV entry factors than a functional genomics screening experiment [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>]; and 3) contain domains that can bind short linear motifs that are also present in many antiviral peptides with experimentally demonstrated activities against HCV infection. These results suggest that, to eliminate viral infection, more attention should be paid to sequence motifs involved in host protein-protein interactions because these motifs may be subject to molecular mimicry by viruses.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>A SLiM-derived HCV-human PPI network</title>
<p>We identified 19 SLiMs on HCV E1 and E2 that might bind various human protein domains (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>). Screening for human hepatocyte surface proteins in conjunction with the available human PPI network yielded 115 VIPs<sub>direct</sub> containing at least one SLiM-binding domain. These proteins and their VIPs<sub>indirect</sub>, which interact with them, constitute a subset of the experimentally derived human PPI network [<xref ref-type="bibr" rid="pcbi.1005368.ref014">14</xref>] that might be directly or indirectly influenced by the mimicking HCV SLiMs. It follows, according to the premise of our molecular mimicry strategy, that the host VIPs<sub>direct</sub> and VIPs<sub>indirect</sub> potentially facilitate or inhibit HCV entry and, along with the viral SLiMs, they formed a viral-host PPI network (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B and 1C</xref>).</p>
</sec>
<sec id="sec004">
<title>Functional modules and network roles</title>
<p>Given a network, algorithms are available to extract network properties [<xref ref-type="bibr" rid="pcbi.1005368.ref017">17</xref>]. Using NetCarto, a tool for network module discovery [<xref ref-type="bibr" rid="pcbi.1005368.ref018">18</xref>], we found that the resulting viral-host PPI network for HCV infection is organized into eight modules with 23 R6 (global connector) hubs (<xref ref-type="fig" rid="pcbi.1005368.g002">Fig 2</xref>). A global connector hub (R6) is defined as a node with many links to most of the other network modules (see <xref ref-type="sec" rid="sec011">Methods</xref> for definitions on roles of network nodes), and as such it is thought to play an important role in connecting different functional modules. Consistent with the definition, whereas most of the 115 VIPs<sub>direct</sub> interact with only a few other host proteins, these 22 R6 hub proteins (the twenty-third R6 hub is a viral SLiM) have many interaction partners. This may imply that these R6 hubs could be important host factors for HCV infection, and could serve as targets for designing anti-HCV drugs (see AVPs analysis below). Further analysis showed that 15 out of the 22 R6 hubs (P &lt; 2.2 × 10<sup>−16</sup>; <xref ref-type="supplementary-material" rid="pcbi.1005368.s001">S1 Fig</xref>) were also hub proteins in the experimentally derived PPI network of human liver cell surface proteins, suggesting that most of these VIPs<sub>direct</sub> R6 hubs have important functions for the host, irrespective of HCV infection. This is in line with the finding that viruses tend to target host hub proteins for perturbing key pathways (or biological processes) to benefit viral infections [<xref ref-type="bibr" rid="pcbi.1005368.ref019">19</xref>]. Interestingly, Gene Ontology (GO) enrichment analysis [<xref ref-type="bibr" rid="pcbi.1005368.ref020">20</xref>] and Revigo summarization [<xref ref-type="bibr" rid="pcbi.1005368.ref021">21</xref>] of the enriched GO annotations (<xref ref-type="supplementary-material" rid="pcbi.1005368.s011">S1 Table</xref>) revealed that the representative functions of seven of the eight modules belong to one, or both, of the two main functionalities: <italic>entry</italic> and <italic>carcinogenesis</italic> (<xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref> and <xref ref-type="supplementary-material" rid="pcbi.1005368.s012">S2 Table</xref>).</p>
<fig id="pcbi.1005368.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Modules and roles of the nodes of the HCV-Human PPI network.</title>
<p>The network was produced using the procedures described in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1A–1C</xref>, with the modules and the roles of network nodes determined by NetCarto (see <xref ref-type="sec" rid="sec011">Methods</xref>). The three types of network nodes are represented as triangles for SLiMs; circles for VIPs<sub>direct</sub>; and squares for VIPs<sub>indirect</sub>. Their network roles (R7 to R1) are depicted as symbols of decreasing size. All nodes are color-coded according to their module. A representative function(s) of each module was derived from an enrichment analysis of GO terms associated with its nodes followed by a summary of Revigo representatives [<xref ref-type="bibr" rid="pcbi.1005368.ref021">21</xref>] (see <xref ref-type="sec" rid="sec011">Methods</xref> and <xref ref-type="supplementary-material" rid="pcbi.1005368.s011">S1 Table</xref>). Colored in gray in the lower right corner are eight isolated nodes.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g002" xlink:type="simple"/>
</fig>
<fig id="pcbi.1005368.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Relationships between SLiMs, R6 VIPs, and network modules.</title>
<p>Of the 19 SLiMs identified for HCV E1 and E2 in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1C</xref>, 13 (including six grouped in the MOD_family; top row) are directly connected to one or more of the 22 R6 VIPs<sub>direct</sub> (middle row) in the virus-host PPI network (<xref ref-type="fig" rid="pcbi.1005368.g002">Fig 2</xref>). The MOD_family contains MOD_CK1_1, MOD_CK2_1, MOD_GSK3_1, MOD_NEK2_1, MOD_NEK2_2, and MOD_ProDKin_1; all are targets of a kinase. An R6 VIP<sub>direct</sub> and a module(s) (bottom, boxed in black) are considered to be connected if more than 10% of the interacting partners of the VIP<sub>direct</sub> belong to the module. Based on this criterion, module 2 is not connected to an R6 VIP<sub>direct</sub> and, therefore, is not included in the figure. The validity of the connections displayed as solid dark lines is supported by published experimental evidence. The corresponding reference number(s) (indicated by an asterisk) are provided in <xref ref-type="supplementary-material" rid="pcbi.1005368.s013">S3 Table</xref>. The dark and light horizontal bars at the bottom of the figure identify modules with the functionality of <italic>entry</italic> and/or <italic>carcinogenesis</italic>, respectively.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g003" xlink:type="simple"/>
</fig>
<p>As described below, much experimental data is available to support our <italic>in silico</italic> observations. For example, “<italic>Cytoskeleton organization</italic>” (modules 1 and 7; Figs <xref ref-type="fig" rid="pcbi.1005368.g002">2</xref> and <xref ref-type="fig" rid="pcbi.1005368.g003">3</xref>) is an essential cellular process that allows HCV to migrate to the tight junction where internalization and endocytosis of the virion occur [<xref ref-type="bibr" rid="pcbi.1005368.ref022">22</xref>]. Notably, some of the proteins of the R6 hubs are involved in this cellular process. According to our hypothesis, cellular processes involved in “<italic>Cytoskeleton organization</italic>” might be hijacked by HCV if one or more of its E1/E2 SLiMs can bind at least one of the following six R6 proteins (in this work we use official gene symbols to represent proteins encoded by the corresponding genes): PIK3R1, which enhances actin reorganization by activating PI3K-AKT signaling [<xref ref-type="bibr" rid="pcbi.1005368.ref023">23</xref>]; SRC, which induces changes in the cytoskeleton by binding and activating FAK [<xref ref-type="bibr" rid="pcbi.1005368.ref024">24</xref>]; and ABL1 [<xref ref-type="bibr" rid="pcbi.1005368.ref025">25</xref>], GRB2 [<xref ref-type="bibr" rid="pcbi.1005368.ref026">26</xref>], NCK1 [<xref ref-type="bibr" rid="pcbi.1005368.ref027">27</xref>], and CTTN [<xref ref-type="bibr" rid="pcbi.1005368.ref028">28</xref>], proteins which regulate cytoskeleton rearrangement.</p>
<p>A function found for module 5 is “<italic>apoptosis</italic>” (Figs <xref ref-type="fig" rid="pcbi.1005368.g002">2</xref> and <xref ref-type="fig" rid="pcbi.1005368.g003">3</xref>), which is an essential cellular process as it prevents HCV from spreading in the host by inducing the death of HCV-infected cells [<xref ref-type="bibr" rid="pcbi.1005368.ref029">29</xref>]. However, E2 can suppress cellular apoptosis resulting in HCV survival [<xref ref-type="bibr" rid="pcbi.1005368.ref030">30</xref>]. In our viral-host PPI network, there are five module 5-associated R6 proteins, four of them, AKT1 [<xref ref-type="bibr" rid="pcbi.1005368.ref023">23</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref031">31</xref>], CHUK [<xref ref-type="bibr" rid="pcbi.1005368.ref032">32</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref033">33</xref>], PRKCA [<xref ref-type="bibr" rid="pcbi.1005368.ref034">34</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref035">35</xref>], and TGFBR1 [<xref ref-type="bibr" rid="pcbi.1005368.ref036">36</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref037">37</xref>] have a role in apoptosis and their activities and/or expressions are known to be affected by HCV infection, although the specific effects of E1 and/or E2 on CHUK, PRKCA, and TGFBR1 activities have yet to be determined. The apoptosis-regulating role of the fifth R6 protein PRKCD [<xref ref-type="bibr" rid="pcbi.1005368.ref038">38</xref>] during HCV infection has also not been examined.</p>
<p>Another representative function of module 7, “<italic>receptor signaling</italic>,” contributes to HCV entry [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>] and carcinogenesis [<xref ref-type="bibr" rid="pcbi.1005368.ref040">40</xref>]. Specifically, HCV infection triggers EGFR signaling and stimulates its downstream signaling, including those of HRAS and PI3K-AKT [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>]. Activation of these pathways enhances HCV entry [<xref ref-type="bibr" rid="pcbi.1005368.ref023">23</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>] and increases the proliferation of hepatocytes, which may contribute to hepatocellular carcinogenesis [<xref ref-type="bibr" rid="pcbi.1005368.ref040">40</xref>]. Three R6 proteins are associated with receptor signaling: PIK3R1, a PI3K subunit and a crucial participant in PI3K-AKT signaling [<xref ref-type="bibr" rid="pcbi.1005368.ref041">41</xref>], and GRB2 [<xref ref-type="bibr" rid="pcbi.1005368.ref042">42</xref>] and SHC1 [<xref ref-type="bibr" rid="pcbi.1005368.ref043">43</xref>], two key adaptor proteins of EGFR signaling, which when silenced substantially impair HCV entry [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>].</p>
<p>Additional published experimental data that support the relationships between the R6 proteins and the functions of the viral-host PPI network modules are summarized in <xref ref-type="supplementary-material" rid="pcbi.1005368.s013">S3 Table</xref>.</p>
</sec>
<sec id="sec005">
<title>VIPs also found in PHISTO and EHCO</title>
<p>We identified 899 VIPs using our scheme. To evaluate the validity of our findings, we compared our list of VIPs with those in the PHISTO (Pathogen-Host Interaction Search Tool) dataset, which contains a list of experimentally verified HCV-interacting human proteins [<xref ref-type="bibr" rid="pcbi.1005368.ref016">16</xref>]. There are a total of 698 HCV-interacting human proteins in PHISTO, of which 160 are in the set of 2,456 liver cell surface proteins (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>). Of the 160 HCV-interacting hepatocyte surface proteins, 158 are annotated specifically as interacting with the polyprotein of HCV (<xref ref-type="supplementary-material" rid="pcbi.1005368.s014">S4 Table</xref>), which contains E1 and E2. As shown in <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2A Fig</xref>, the 899 VIPs tended to contain members from the 158 subset of the PHISTO list, with 92 proteins overlapped between the two (P = 9.2 × 10<sup>−9</sup>; <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2A Fig</xref>). Similarly, the predicted interactions between HCV(SLiMs) and VIPs, i.e. the edges of the viral-host PPI network, were enriched in PHISTO (P = 4.3 × 10<sup>−4</sup> and 9.6 × 10<sup>−5</sup> for direct and indirect interactions, respectively; see <xref ref-type="supplementary-material" rid="pcbi.1005368.s003">S3 Fig</xref> and <xref ref-type="supplementary-material" rid="pcbi.1005368.s014">S4 Table</xref>). These results indicate that our bioinformatics approach preferentially identified HCV-interacting human proteins.</p>
<p>Four of the identified virus-host PPI network modules are associated with carcinogenic processes (<xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref>), which is a somewhat unexpected result as E1 and E2 are usually only considered to be entry proteins [<xref ref-type="bibr" rid="pcbi.1005368.ref013">13</xref>]; however, this association is consistent with known oncogenic effects of E1 and E2 [<xref ref-type="bibr" rid="pcbi.1005368.ref044">44</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref045">45</xref>]. To further evaluate the involvement of the VIPs in hepatocellular carcinoma (HCC), we assessed if a significant number of those VIPs are found in the EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online) [<xref ref-type="bibr" rid="pcbi.1005368.ref015">15</xref>] dataset. Of the 614 genes that are differentially expressed in HCV-caused HCC in EHCO, 194 are expressed on liver cell surface, and 91 of their encoded proteins were identified as VIPs (P = 1.4 × 10<sup>−3</sup>; <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2B Fig</xref>), further supporting the notion that E1/E2 interact with host proteins that have a role in carcinogenesis.</p>
</sec>
<sec id="sec006">
<title>Comparison with a siRNA-screening experiment list</title>
<p>Recently, a set of host factors for HCV entry was identified in a large-scale siRNA screening experiment reported by Li and coworkers [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>]. However, the authors of that study identified only four of the 15 human proteins found on hepatocyte surface and known to be associated with HCV entry (<xref ref-type="table" rid="pcbi.1005368.t001">Table 1</xref>). By comparison, we identified 11 of these entry factors known before Li and colleagues performed their study, and we also identified the four proteins found by them (<xref ref-type="table" rid="pcbi.1005368.t001">Table 1</xref>). Three of the known entry factors that our study did not find, CLDN1, SCARB1, and CD209, are connected to at least one VIP<sub>indirect</sub> in the human PPI network, but are not VIPs themselves (<xref ref-type="supplementary-material" rid="pcbi.1005368.s004">S4A–S4C Fig</xref>). The fourth, NPC1L1, which we did not identify, lacks information of interaction with any of the VIPs in the network (<xref ref-type="supplementary-material" rid="pcbi.1005368.s004">S4D Fig</xref>).</p>
<table-wrap id="pcbi.1005368.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.t001</object-id>
<label>Table 1</label> <caption><title>Comparison with known entry factors of HCV infection.</title></caption>
<alternatives>
<graphic id="pcbi.1005368.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2" style="background-color:#FFFFFF">Gene symbol</th>
<th align="center" rowspan="2" style="background-color:#FFFFFF">Protein name</th>
<th align="center" colspan="3" style="background-color:#FFFFFF">Identified <xref ref-type="table-fn" rid="t001fn001"><sup>a</sup></xref></th>
</tr>
<tr>
<th align="center" style="background-color:#FFFFFF">This study (15)</th>
<th align="center" style="background-color:#FFFFFF">Li_2014<xref ref-type="table-fn" rid="t001fn002"><sup>b</sup></xref> (8)</th>
<th align="center" style="background-color:#FFFFFF">Literature<xref ref-type="table-fn" rid="t001fn003"><sup>c</sup></xref> (15)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" style="background-color:#FFFFFF">CD81</td>
<td align="left" style="background-color:#FFFFFF">CD81 antigen</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">CDC42</td>
<td align="left" style="background-color:#FFFFFF">CDC42</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">RAC1</td>
<td align="left" style="background-color:#FFFFFF">Ras related C3 botulinum toxin substrate 1</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">APOE</td>
<td align="left" style="background-color:#FFFFFF">Apolipoprotein E</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">EGFR</td>
<td align="left" style="background-color:#FFFFFF">EGF receptor</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">EPHA2</td>
<td align="left" style="background-color:#FFFFFF">EphA2</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">HRAS</td>
<td align="left" style="background-color:#FFFFFF">H-Ras</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">LDLR</td>
<td align="left" style="background-color:#FFFFFF">Low density lipoprotein receptor</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">OCLN</td>
<td align="left" style="background-color:#FFFFFF">Occludin</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">PCSK9</td>
<td align="left" style="background-color:#FFFFFF">Proprotein convertase PC9</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">TFRC</td>
<td align="left" style="background-color:#FFFFFF">Transferrin receptor</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">CLDN1</td>
<td align="left" style="background-color:#FFFFFF">Claudin 1</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">CD209</td>
<td align="left" style="background-color:#FFFFFF">DC-SIGN</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">NPC1L1</td>
<td align="left" style="background-color:#FFFFFF">NPC1 like 1</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">SCARB1</td>
<td align="left" style="background-color:#FFFFFF">Scavenger receptor class B member 1</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">N</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">ARHGEF7</td>
<td align="left" style="background-color:#FFFFFF">Rho guanine nucleotide exchange factor 7</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">CDH1</td>
<td align="left" style="background-color:#FFFFFF">Cadherin-1 precursor</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">RAB34</td>
<td align="left" style="background-color:#FFFFFF">Ras-related protein Rab-34, isoform NARR</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
</tr>
<tr>
<td align="center" style="background-color:#FFFFFF">RBP4</td>
<td align="left" style="background-color:#FFFFFF">Retinol-binding protein 4 precursor</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">Y</td>
<td align="center" style="background-color:#FFFFFF">N</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>a</sup> Y, yes; N, no.</p></fn>
<fn id="t001fn002"><p><sup>b</sup>Eight proteins (ARRDC2, CHKA, CYBA, DDX3X, FASN, MAP4, PIK4CA, and ROCK2) identified in [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>] as HCV entry factors are not expressed on the liver cell surface according to the HPRD [<xref ref-type="bibr" rid="pcbi.1005368.ref046">46</xref>] and the Human Proteinpedia [<xref ref-type="bibr" rid="pcbi.1005368.ref047">47</xref>]; thus, these factors were excluded from our analysis.</p></fn>
<fn id="t001fn003"><p><sup>c</sup>Proteins annotated with “Entry” and “Attachment” in the column of “HCV Life Cycle Stages Affected” in S9 Table in [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>] were compared, however CLEC4M, FASN, IFITM1, PIK4CA, ROCK2, and SDC1 in S9 Table of the report were not included because they were not expressed on the liver cell surface according to the HPRD [<xref ref-type="bibr" rid="pcbi.1005368.ref046">46</xref>] and the Human Proteinpedia [<xref ref-type="bibr" rid="pcbi.1005368.ref047">47</xref>].</p></fn>
</table-wrap-foot>
</table-wrap>
<p>CD81, OCLN, CLDN1 and SCARB1 are arguably the four best known HCV entry-related factors [<xref ref-type="bibr" rid="pcbi.1005368.ref048">48</xref>]. Of them, we identified CD81 and OCLN as VIPs<sub>indirect</sub> but failed to find CLDN1 and SCARB1 as noted above. Interestingly, transgenic expression of human CD81 and OCLN in mouse enabled HCV infection of mouse hepatocytes, whereas transgenic expression of human CLDN1 or SCARB1 was not necessary for mouse cell to be infected by HCV [<xref ref-type="bibr" rid="pcbi.1005368.ref049">49</xref>]. As a VIP<sub>indirect</sub>, CD81 is not predicted to possess a domain that can directly bind an E1/E2 SLiM, which might be considered to contradict a report suggesting a physical interaction between HCV E2 and CD81 [<xref ref-type="bibr" rid="pcbi.1005368.ref050">50</xref>] can occur. Nonetheless, viruses employ other strategies to interact with host proteins [<xref ref-type="bibr" rid="pcbi.1005368.ref007">7</xref>], and indeed, substitution mutation experiments suggested that HCV E2 uses a non-sequential motif to bind CD81 [<xref ref-type="bibr" rid="pcbi.1005368.ref051">51</xref>], which we would not have uncovered using the SLiM-based approach. Altogether, our approach found more known HCV hepatocyte entry host factors (15 of 19 (79%); <xref ref-type="table" rid="pcbi.1005368.t001">Table 1</xref>) than did the siRNA functional genomics-screening assay of Li and colleagues. Furthermore, an ROC (Receiver Operating Characteristic [<xref ref-type="bibr" rid="pcbi.1005368.ref052">52</xref>]) curve analysis accounting for not only sensitivity but also specificity showed that the <italic>in silico</italic> predictions yielded an AUC (area under curve) of 0.68, which is almost as good as that (0.70) of Li et al.’s experimental screening (<xref ref-type="supplementary-material" rid="pcbi.1005368.s005">S5 Fig</xref>). Note that including protein complexes in the analysis (see below) significantly improved on specificity for the <italic>in silico</italic> predictions while maintaining the overall performance; similarly, in Li et al.’s experiment, a large number of genes (19,277) had been removed by a genome-wide genetic screen [<xref ref-type="bibr" rid="pcbi.1005368.ref053">53</xref>] prior to the siRNA functional analysis [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>], and these were not included in the ROC curve analysis, giving rise to a much higher specificity for Li et al.’s experiment (<xref ref-type="supplementary-material" rid="pcbi.1005368.s005">S5 Fig</xref>). In addition, because all of those we predicted as novel ones were treated as false positives in these calculations, the actual performance of our predictions could possibly be better.</p>
</sec>
<sec id="sec007">
<title>Protein complexes and KEGG pathways</title>
<p>Viruses are known to target protein complexes so as to heavily perturb host functions and induce disease states, e.g., carcinogenesis [<xref ref-type="bibr" rid="pcbi.1005368.ref006">6</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref054">54</xref>]. It is, therefore, of interest to identify human protein complexes that might be perturbed by HCV infection, including those involving VIPs<sub>direct</sub> and VIPs<sub>indirect</sub>. Knowledge of such protein complexes would also greatly reduce the number of VIPs needed to be considered for pathway analysis and experimentation.</p>
<p>By mapping the VIPs to protein complexes in the HPRD [<xref ref-type="bibr" rid="pcbi.1005368.ref046">46</xref>] and CORUM [<xref ref-type="bibr" rid="pcbi.1005368.ref055">55</xref>] databases (these databases categorize human and mammalian protein complexes, respectively) and clustering according to shared subunits, we identified six groups of protein complexes (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref> and <xref ref-type="supplementary-material" rid="pcbi.1005368.s006">S6 Fig</xref> and <xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>) that HCV may target by interaction with the VIPs of the complexes. These six groups contain 231 of the 899 VIPs and nine of the 19 viral SLiMs, with six of the nine SLiMs capable of binding the same protein domains (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>). A comparison of our results with those obtained using the same mapping procedure and the same number of randomly selected proteins showed that the tendency of the HCV SLiMs-derived VIPs to be present in these protein complexes is unlikely to occur by chance (P &lt; 1.0 × 10<sup>−5</sup>; <xref ref-type="supplementary-material" rid="pcbi.1005368.s007">S7 Fig</xref>). Furthermore, 11 of the 22 R6 hub proteins are present in these HCV-targeted complexes, (P = 1.1 × 10<sup>−2</sup>; <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2C Fig</xref>). Moreover, these 231 VIPs are significantly enriched by members of the PHISTO, EHCO, and known HCV entry factor lists (P = 1.5 × 10<sup>−11</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2D Fig</xref>; P = 1.8 × 10<sup>−7</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2E Fig</xref>; and P = 4.8 × 10<sup>−3</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s002">S2F Fig</xref>; respectively).</p>
<fig id="pcbi.1005368.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g004</object-id>
<label>Fig 4</label>
<caption>
<title>The AVP/SLiM-protein complex map.</title>
<p>Top panel: (left column) a list of AVPs with their AVPdb identification numbers that have an amino acid sequence containing one or more HCV E1/E2 SLiMs (indicated by the triangles and named at the bottom of the panel) that can bind to a subunit of a protein complex belonging to one of the six main complex groups. The relative efficacies of these AVPs in inhibiting HCV entry according to data provided in the AVPdb [<xref ref-type="bibr" rid="pcbi.1005368.ref056">56</xref>] are indicated by the circles column in the panel with the shading score shown to the right of the panel. Middle panel: the network connecting the nine SLiMs to their group A-F complex target(s). Within each group are VIPs of all the complexes: ovals represent VIPs<sub>direct</sub> (gray ovals are R6 VIPs<sub>direct</sub>), and rectangles represent VIPs<sub>indirect</sub> (not all VIPs<sub>indirect</sub> are shown). The ovals and rectangles in bold outline are known HCV entry factors. The horizontal bar represents the plasma membrane, the VIPs below the bar and within the shaded area are ‘peripheral membrane proteins’, and those spanning the bar are ‘integral membrane proteins’. APOE is a peripheral membrane protein located at the extracellular side of the cell membrane. A connection between a viral SLiM and a complex group indicates that at least one protein in the group is targeted by HCV E1 and/or E2 via the viral SLiM. The thickness of the connection roughly scales to the number of proteins targeted by the SLiM in the group. The three numbers in the parenthesis are the number of VIPs<sub>direct</sub>, total VIPs (i.e., VIPs<sub>direct</sub> plus VIPs<sub>indirect</sub>), and unique subunits in the complex group. Bottom panel: the KEGG pathways enriched in the complex group (Benjamini-Hochberg adjusted P &lt; 0.001) (see <xref ref-type="supplementary-material" rid="pcbi.1005368.s016">S6 Table</xref> for the pathway names). The gray scale at bottom right indicate the significance of the P-values. The functions of the individual KEGG pathways are shown at the left of the panel and the main functionality at the right of the panel.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g004" xlink:type="simple"/>
</fig>
<p>Two known HCV entry factors, APOE and HRAS, and a novel entry factor ITGB identified by Zona and colleagues [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>] are components of a single complex with CD81 [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref057">57</xref>]. Of this CD81-complex, we identified several subunits, ADAM10, APOE, CD59, CD9, HRAS, ITGB1 and SCAM, as VIPs, this complex hence meets our criterion of ≥3 VIPs for an HCV-targeted host protein complex even though information of this complex was not used in our analysis because the latest compilations of CORUM and HPRD, in 2012 and 2009, respectively, predate the work of Zona and colleagues. This example therefore illustrates the merit of our approach in general, and the inclusion of protein complexes in the analysis in particular.</p>
<p>As detailed in the <xref ref-type="supplementary-material" rid="pcbi.1005368.s017">S1 Appendix</xref>, there are three main functionalities associated with KEGG pathways that are enriched in the HCV-targeted protein complexes: <italic>entry</italic>, <italic>carcinogenesis</italic>, and <italic>infectious disease</italic>; the first two overlap substantially, as is shown by the analysis of the GO enrichment terms associated with the network modules (<xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref>). Examination of the KEGG pathways enriched in complex-forming VIPs helps us to understand the roles the complexes might play during HCV infection. For example, <italic>TGF-beta signaling</italic> (P = 1.2 × 10<sup>−6</sup>), <italic>Endocytosis</italic> (P = 4.8 × 10<sup>−11</sup>), and <italic>Adherens junction</italic> (P = 7.6 × 10<sup>−7</sup>) are among KEGG pathways enriched in group C complexes (<xref ref-type="supplementary-material" rid="pcbi.1005368.s016">S6 Table</xref>) in which the VIPs<sub>direct</sub> TGFBR1, TGFBR2, ACVR1B, and ACVR1C are signaling receptors [<xref ref-type="bibr" rid="pcbi.1005368.ref058">58</xref>] and PRKCZ and PRKCI are protein kinases involved in endocytosis and adherens junction remodeling [<xref ref-type="bibr" rid="pcbi.1005368.ref059">59</xref>]. Our analysis revealed that several of the enriched pathways are involved in more than one step of HCV entry, and that the envelope proteins may regulate immune responses to HCV infection, affect hormone-related signaling pathways, and modulate HCC progression. These suggestions are in line with many experimental studies (<xref ref-type="supplementary-material" rid="pcbi.1005368.s017">S1 Appendix</xref>), including the report that HCV E1 and E2 can alter <italic>RIG-I-like receptor signaling</italic> and <italic>Toll-like receptor signaling</italic> [<xref ref-type="bibr" rid="pcbi.1005368.ref060">60</xref>]. Finally, the presence of enriched pathways associated with <italic>infectious disease</italic> suggests that some of the VIP-containing protein complexes may also be targets of other viruses, which is consistent with reports of coinfection of two or more different viruses (see, e.g. [<xref ref-type="bibr" rid="pcbi.1005368.ref061">61</xref>]).</p>
<p>However, when compared to all the SLiM-binding hepatocyte surface proteins and their binding partners in the human PPI network, the identified HCV-targeted protein complexes were shown to be significantly enriched in KEGG pathways belonging to the functionality of <italic>cell entry</italic> (P = 3.7 × 10<sup>−2</sup>) and <italic>carcinogenesis</italic> (P = 2.7 × 10<sup>−2</sup>), but not <italic>infectious disease</italic> (P = 3.8 × 10<sup>−1</sup>) (see <xref ref-type="supplementary-material" rid="pcbi.1005368.s008">S8 Fig</xref>). This may suggest that <italic>infectious disease</italic> is more likely than the other two functionalities to be influenced by many of these proteins with a domain that can bind other SLiMs of the ELM database.</p>
</sec>
<sec id="sec008">
<title>AVPs and SLiMs</title>
<p>Peptides that can interfere with virus-host interactions are potential antiviral drugs [<xref ref-type="bibr" rid="pcbi.1005368.ref062">62</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref063">63</xref>]. The viral SLiMs that we identified may, therefore, be useful scaffolds upon which to build AVPs. A search of the AVPdb [<xref ref-type="bibr" rid="pcbi.1005368.ref056">56</xref>] returned 73 AVPs that have been examined for entry-related, anti-HCV infection (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1D</xref>), with more than one-third (29) harboring at least one of the nine identified SLiMs that might target a VIP residing in at least one of the six main protein complex groups. A statistical test indicated that these nine SLiMs were as likely to be also present in other AVPs (P = 8.8 × 10<sup>−1</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s009">S9A Fig</xref>), suggesting that, besides SLiMs, other parts of the AVP sequences are required to determine entry-related anti-HCV activities. Notably, however, many of the 29 AVPs have been shown to actively suppress HCV entry in cell-based assays (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>, top panel). Although the molecular mechanisms associated with the anti-HCV activities of these AVPs have not been fully elucidated, it is tempting to speculate that, because they contain an HCV SLiM, they may interfere with an HCV-host protein interaction by preferentially binding the host protein and, thereby, inhibiting HCV entry.</p>
</sec>
<sec id="sec009">
<title>Case examples</title>
<p>We present two examples to demonstrate how our bioinformatics procedures can be used to identify protein complexes known to play a role in HCV infection and/or pathology.</p>
<p>The first example (<xref ref-type="fig" rid="pcbi.1005368.g005">Fig 5A</xref>), involves the complex containing EGFR, SHC1, and GRB2 (group F complex, <xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>). This complex (<xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>, complex ID: 176) mediates HRAS signaling critical for HCV entry [<xref ref-type="bibr" rid="pcbi.1005368.ref039">39</xref>]. According to our results, HCV E1/E2 might interact directly with SHC1 and GRB2 (both are R6 VIPs<sub>direct</sub>) and indirectly with EGFR (a VIP<sub>indirect</sub>) via the SLiMs of LIG_SH2_STAT5 and/or LIG_SH3_3 (<xref ref-type="fig" rid="pcbi.1005368.g005">Fig 5A and 5C</xref>). Furthermore, of the 23 AVPs that contain the same SLiM (22 with LIG_SH2_STAT5 and one with LIG_SH3_3), 20 (86%) are shown to inhibit HCV entry (<xref ref-type="fig" rid="pcbi.1005368.g005">Fig 5C, I and II</xref>), and this percentage is shown to be statistically significant (P &lt; 1.0 × 10<sup>−4</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s009">S9B Fig</xref>).</p>
<fig id="pcbi.1005368.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Case examples.</title>
<p><bold>(A)</bold> The EGFR-associated complex (<xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>, Complex ID: 176). <bold>(B)</bold> The AKT1-associated complex (<xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>, Complex ID: 180). <bold>(C)</bold> Types of SLiM-domain interactions (indicated by (1), (2), and (3)) that mediate the targeting of protein complexes, and three sets of AVPs (indicated by (I), (II) and (III)) containing the corresponding SLiM that exhibits inhibition activity (indicated by bar-headed arrows) are shown. Proteins represented by black ovals are VIPs<sub>direct</sub>; by gray ovals are VIPs<sub>indirect</sub>; and by white ovals are not VIPs (i.e. not in the virus-host PPI network). Double-headed arrows in panel A and B indicate predicted HCV-host PPIs in our analysis. Viral SLiM(s) are highlighted within the amino acid sequence of the AVP and are accompanied by its relative efficacy (in shaded circles) in inhibiting HCV entry (see the vertical bar for the normalized inhibition score in <xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref> on the right of its top panel). The regular expression of each SLiM sequence as annotated in the ELM database [<xref ref-type="bibr" rid="pcbi.1005368.ref011">11</xref>] is shown within quotation marks in the SLiM-domain interactions (1), (2), and (3). *EGFR is a known HCV entry factor. **MOD_ProDKin_1 is representative of the MOD_family SLiMs (see <xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref>).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g005" xlink:type="simple"/>
</fig>
<p>The second example, the AKT1-associated complex (also a group F complex, <xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>), is presented in <xref ref-type="fig" rid="pcbi.1005368.g005">Fig 5B</xref>. When being a part of this complex (<xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>, complex ID: 180), AKT1 can inhibit apoptosis induced by BAD overexpression [<xref ref-type="bibr" rid="pcbi.1005368.ref064">64</xref>], and inhibition of BAD-mediated apoptosis contributes to HCC progression [<xref ref-type="bibr" rid="pcbi.1005368.ref065">65</xref>]. Our analysis suggests that HCV E1 and/or E2 may interact with the AKT1-associated complex by targeting one or more of its members, i.e., AKT1 and PAK1 through SLiMs of the MOD_family (MOD_NEK2_2 of E1; MOD_CK1_1, MOD_CK2_1, MOD_GSK3_1, MOD_NEK2_1 of E2, and MOD_ProDKin_1 of E1 and E2), and SORBS2, an SH3 domain-containing protein, through the SLiM of LIG_SH3_3. Together with the report that HCV E2 can induce AKT phosphorylation to facilitate HCV entry [<xref ref-type="bibr" rid="pcbi.1005368.ref023">23</xref>], these results suggest that a viral SLiM and protein domain association may be involved in viral entry and virus-induced carcinogenesis. Furthermore, as with the first example, the majority (four out of seven; P &lt; 1.0 × 10<sup>−4</sup>, <xref ref-type="supplementary-material" rid="pcbi.1005368.s009">S9C Fig</xref>) of the AVPs containing a MOD_family SLiM inhibits HCV entry (<xref ref-type="fig" rid="pcbi.1005368.g005">Fig 5C</xref> (III)).</p>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Discussion</title>
<p>Despite recent, rapid advances in high-throughput experiments, all characterized networks of virus-host interactions remain vastly incomplete. To fill this void, several studies have incorporated bioinformatics information [<xref ref-type="bibr" rid="pcbi.1005368.ref066">66</xref>] such as that obtained by text mining experimental reports from the literature [<xref ref-type="bibr" rid="pcbi.1005368.ref067">67</xref>]. In this work, we described a strategy, identifying eukaryote-interacting SLiMs found in viruses to find human proteins that may be “hijacked” by HCV for its entry via “molecular mimicry” of the SLiMs. With the identification of these human proteins, i.e., VIPs, we then built a virus-host PPI network by exploring the human PPI network for functions that may be modulated and/or productively used by the virus.</p>
<p>Per our “molecular mimicry” hypothesis, more than half of the hepatocyte surface proteins could be VIPs for a SLiM from the ELM database to interact with directly or indirectly (1,320/2,456, see <xref ref-type="supplementary-material" rid="pcbi.1005368.s008">S8 Fig</xref> legend), and more than one third (899/2,456, <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>) for a SLiM harbored by HCV E1/E2 alone (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>). This suggests that SLiMs by themselves are of low binding specificity to protein domains, and thus most of the predicted VIPs are likely false positives. However, as demonstrated by the results presented above, by integrating with a variety of experimental data and information, especially with network and functional analysis, the number of VIPs (hence false positives) predicted can be greatly reduced and a manageable list of viable candidate proteins can be extracted to complement and guide further experimental investigations.</p>
<p>Our functional analysis shows that the SLiMs-derived VIPs of HCV infection and the related host protein complexes are involved in two major types of cellular functions, one associated with viral entry and the other with carcinogenesis and/or infectious disease (Figs <xref ref-type="fig" rid="pcbi.1005368.g003">3</xref> and <xref ref-type="fig" rid="pcbi.1005368.g004">4</xref>). Although the inclusion of the second category was somewhat unexpected because HCV E1 and E2 were used to find SLiMs, a role for E1/E2 in carcinogenesis has been demonstrated [<xref ref-type="bibr" rid="pcbi.1005368.ref044">44</xref>, <xref ref-type="bibr" rid="pcbi.1005368.ref045">45</xref>] and multi-functionality of other viral envelope proteins has also been documented [<xref ref-type="bibr" rid="pcbi.1005368.ref068">68</xref>–<xref ref-type="bibr" rid="pcbi.1005368.ref070">70</xref>]: For example, hemagglutinin, an envelope protein of the influenza virus, is involved in viral entry but also activates NF-κB when expressed in 293T and Hela cells [<xref ref-type="bibr" rid="pcbi.1005368.ref069">69</xref>]. Many of the predicted interactions between the SLiMs found in HCV E1/E2 and the human VIPs that occupy a prominent role (R6, global connector hub) in the virus-host PPI network, and the relationships between these R6 VIPs and their deduced functional modules, are supported by published experimental evidence (<xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref>). Together with the results from a similar approach used to predict HIV-interacting human proteins [<xref ref-type="bibr" rid="pcbi.1005368.ref071">71</xref>] and the report that virus-host interactions may be assisted by host-like SLiMs [<xref ref-type="bibr" rid="pcbi.1005368.ref010">10</xref>], evidence is mounting to support the suggestion that, via SLiMs, host proteins can be “hijacked” and host functions rewired by pathogens, a phenomenon that has been extensively reviewed at the pathway level [<xref ref-type="bibr" rid="pcbi.1005368.ref008">8</xref>]. Further supporting this premise, some HCV E1/E2 SLiMs, particularly those that might interact with major protein complexes, are found in many AVPs that inhibit HCV infection (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>).</p>
<p>Although recently approved direct-acting antiviral (DAA) treatments have improved the virologic response rate to &gt;90% for most types of chronic hepatitis C infections, new, hard-to-treat HCV strains including genotype 3 and DAA-resistant variants generated from DAA-treated patients, have appeared [<xref ref-type="bibr" rid="pcbi.1005368.ref072">72</xref>]. Because DAA-resistant strains are disseminated mainly through cell-to-cell transmission rather than cell-free transmission [<xref ref-type="bibr" rid="pcbi.1005368.ref073">73</xref>], the former route will be key to eradicating HCV infection. Several known HCV entry factors for cell-free transmission, e.g., EGFR, CLDN1, OCLN, and SCARB1 are also involved in cell-to-cell transmission [<xref ref-type="bibr" rid="pcbi.1005368.ref074">74</xref>–<xref ref-type="bibr" rid="pcbi.1005368.ref076">76</xref>]. Additionally, cell-to-cell transmission independent of CD81, the most well studied binding receptor for HCV E2 [<xref ref-type="bibr" rid="pcbi.1005368.ref013">13</xref>], has been reported [<xref ref-type="bibr" rid="pcbi.1005368.ref077">77</xref>–<xref ref-type="bibr" rid="pcbi.1005368.ref079">79</xref>]. Taken together and given that HCV E1/E2 are indispensable for cell-to-cell transmission of the virus [<xref ref-type="bibr" rid="pcbi.1005368.ref079">79</xref>], other host factors that can interact with these viral proteins need to be identified. Although the mechanism(s) of HCV cell-to-cell transmission is not yet understood, this type of transmission has been associated with cell adhesion molecules [<xref ref-type="bibr" rid="pcbi.1005368.ref080">80</xref>], many of which belong to the KEGG pathway category of Cellular community. Interestingly, pathways in this category are significantly enriched in four of the six protein complex groups (all except group A and E complexes; <xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>), suggesting that some of the complex-associated VIPs may be a good starting point to study cell-to-cell transmission of HCV. Because host-targeting antivirals are generating enthusiastic interest for the development of treatments for hard-to-treat hepatitis C infections [<xref ref-type="bibr" rid="pcbi.1005368.ref081">81</xref>], our bioinformatics strategy is a timely approach to identify new targets for antiviral research, not only for HCV but also for other viruses as the concept of SLiM involvement in molecular mimicry is a general one.</p>
</sec>
<sec id="sec011" sec-type="materials|methods">
<title>Methods</title>
<p>The four main components of our <italic>in silico</italic> approach are shown in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1</xref>.</p>
<sec id="sec012">
<title>A) Identify viral SLiMs</title>
<p>The HCV E1/E2 sequences were scanned against sequences in the ELM database (<ext-link ext-link-type="uri" xlink:href="http://elm.eu.org/" xlink:type="simple">http://elm.eu.org/</ext-link>) [<xref ref-type="bibr" rid="pcbi.1005368.ref011">11</xref>] to find short, matching linear sequences in mammalian proteins known to interact with other mammalian proteins, which might, therefore, be mimicked by HCV E1/E2 sequences (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1A</xref>). E1 and E2 sequences (from 41 and 35 HCV strains, respectively) were extracted from the UniProtKB/SwissProt database (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/" xlink:type="simple">http://www.uniprot.org/</ext-link>) [<xref ref-type="bibr" rid="pcbi.1005368.ref082">82</xref>] for use in our study. We required that the sequences of the matched viral SLiM needed to be conserved at a rate of at least 70%, a cutoff used for a study of HIV SLiMs by others [<xref ref-type="bibr" rid="pcbi.1005368.ref071">71</xref>] and also yielded the best performance to balance sensitivity and specificity in predicting known HCV entry factors (<xref ref-type="supplementary-material" rid="pcbi.1005368.s005">S5 Fig</xref>). The search retrieved 26 distinct and conserved SLiMs (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1A</xref>), which were then used to find the human proteins (VIPs<sub>direct</sub>) that they might interact with (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>).</p>
<p>As shown in <xref ref-type="supplementary-material" rid="pcbi.1005368.s010">S10 Fig</xref>, the number of SLiMs that can be found in HCV protein sequences is roughly proportional to protein size, and all these proteins can confer the “molecular mimicry” mechanism hypothesized and be targets of our investigation; however, as explained in Introduction, we focused on E1/E2 sequences because we were primarily concerned with the viral entry process, in addition to other considerations.</p>
</sec>
<sec id="sec013">
<title>B) Construct of a virus-host PPI network</title>
<p>Accompanying each SLiM in the ELM database is an annotation of the protein domain(s) to which the SLiM can bind. Of the 26 identified SLiMs, 23 have information for human proteins, and of the 23, 19 were mapped to hepatocyte surface proteins that are present in the Human Integrated Protein-Protein Interaction Reference database [<xref ref-type="bibr" rid="pcbi.1005368.ref014">14</xref>] (HIPPIE release v1.7; <ext-link ext-link-type="uri" xlink:href="http://cbdm-01.zdv.uni-mainz.de/~mschaefer/hippie/" xlink:type="simple">http://cbdm-01.zdv.uni-mainz.de/~mschaefer/hippie/</ext-link>), which is a constantly updated human PPI database that integrate multiple experimental PPI datasets, to derive a PPI network. The list of hepatocyte surface proteins used to develop our virus-host PPI network was collected from Human Protein Reference Database [<xref ref-type="bibr" rid="pcbi.1005368.ref046">46</xref>] (HPRD; <ext-link ext-link-type="uri" xlink:href="http://www.hprd.org/" xlink:type="simple">http://www.hprd.org</ext-link>) and Human Proteinpedia Database (<ext-link ext-link-type="uri" xlink:href="http://www.humanproteinpedia.org/" xlink:type="simple">http://www.humanproteinpedia.org</ext-link>) [<xref ref-type="bibr" rid="pcbi.1005368.ref047">47</xref>] by using the keywords “Liver” or “Hepatocyte” for the tissue type and “Extracellular region,” “Plasma membrane,” “Cell surface,” or “Cell junction” for the type of cellular component to search for potential host proteins expressed on the hepatocyte surface that might facilitate the entry of HCV. A set of 2,456 human proteins matched these keywords, and we termed this set “liver cell surface proteins”. Of these proteins, 115 (VIPs<sub>direct</sub>) contained at least one protein domain to which one of the 19 viral SLiMs could bind which would mimic the corresponding human SLiM. A set of 784 proteins (denoted VIPs<sub>indirect</sub>) were identified as binding partners to the VIPs<sub>direct</sub>. The interactions between the VIPs<sub>direct</sub> and VIPs<sub>indirect</sub>, and those between the viral SLiMs and VIPs<sub>direct</sub> were combined to form the virus-host network, which was then subjected to a network module/functional analysis, as described in the next step and <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1C</xref>.</p>
</sec>
<sec id="sec014">
<title>C) Identify network modules and their functional roles</title>
<p>Given a network, it is useful to determine whether it is formed of modules (i.e., communities), which are often indicative of distinct functions. For this task, we applied the network analysis tool NetCarto [<xref ref-type="bibr" rid="pcbi.1005368.ref018">18</xref>] using its large-network default settings to identify modules. The roles of importance for each network node, including every VIP, could also be assigned, which ranged from the least significant, R1 (ultra-peripheral) and R2 (peripheral), to the most significant, R6 (global connector hub) and R7 (kinless hub) (a hub is a node connected to many nodes). Following NetCarto [<xref ref-type="bibr" rid="pcbi.1005368.ref018">18</xref>], the definitions of the seven classes of network nodes and their roles in the network are summarized and schematically depicted in <xref ref-type="fig" rid="pcbi.1005368.g006">Fig 6</xref>.</p>
<fig id="pcbi.1005368.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pcbi.1005368.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Definitions and schematic depictions of network roles.</title>
<p>According to NetCarto [<xref ref-type="bibr" rid="pcbi.1005368.ref018">18</xref>], nodes (small red circles) with z-score of within-module degree ≥ 2.5 are defined as module hubs (nodes with many links, i.e. spikes in the schematic view), and those with z-score &lt; 2.5 are non-hubs. Large circles represent modules. See [<xref ref-type="bibr" rid="pcbi.1005368.ref018">18</xref>] for further details.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.g006" xlink:type="simple"/>
</fig>
<p>The biological function of each network module was inferred using DAVID (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/" xlink:type="simple">https://david.ncifcrf.gov/</ext-link>) [<xref ref-type="bibr" rid="pcbi.1005368.ref083">83</xref>] to search for enriched GO functions [<xref ref-type="bibr" rid="pcbi.1005368.ref020">20</xref>] under the category of “biological process.” For each module, Revigo [<xref ref-type="bibr" rid="pcbi.1005368.ref021">21</xref>] was used to obtain representatives for enriched GO terms (Benjamini–Hochberg-adjusted P &lt; 0.05), and a main functionality was deduced to cover these representatives.</p>
</sec>
<sec id="sec015">
<title>D) Build the AVP/SLiM-protein complex map</title>
<p>Because host VIPs<sub>direct</sub> and VIPs<sub>indirect</sub> may be subunits of the same protein complex targeted by the virus, we mapped the VIPs to the human protein complexes in HPRD [<xref ref-type="bibr" rid="pcbi.1005368.ref046">46</xref>] and in the mammalian protein complexes database (CORUM) [<xref ref-type="bibr" rid="pcbi.1005368.ref055">55</xref>]. The 190 complexes containing three or more VIPs were then clustered by GAP [<xref ref-type="bibr" rid="pcbi.1005368.ref084">84</xref>], a tool for matrix visualization and clustering, based on similarity related to the number of common subunits. The choice of three VIPs was made to reduce the total number of VIPs for enrichment analysis while maintaining their coverage of known HCV entry factors as much as possible. This procedure yielded six major protein-complex clusters, or groups (small groups containing fewer than five complexes were excluded), which altogether contained 177 complexes and 231 VIPs that were linked to nine viral SLiMs. The VIPs of each of the six complex groups were then subjected to KEGG pathway enrichment analysis [<xref ref-type="bibr" rid="pcbi.1005368.ref085">85</xref>] using the clusterProfiler R package [<xref ref-type="bibr" rid="pcbi.1005368.ref086">86</xref>]. A total of 43 significantly enriched hepatocyte-expressed pathways were identified (Benjamini-Hochberg-adjusted P &lt; 0.001). In addition, a search of AVPdb [<xref ref-type="bibr" rid="pcbi.1005368.ref056">56</xref>] identified 73 peptides annotated with “Hepatitis C virus” and “Virus entry” whose inhibiting activities against HCV entry have been examined by experimental screening. Of the 73 sequences, 29 matched at least one of the nine viral SLiMs. Matching of the AVP sequences and viral SLiMs was performed at the ELM database website.</p>
</sec>
</sec>
<sec id="sec016">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1005368.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Statistical significance of VIPs<sub>direct</sub> being hub proteins (R6 or R7) in the host PPI network.</title>
<p>The P-value was computed using a binomial proportion test on the difference between the group of 22 R6 VIPs<sub>direct</sub> and that of the remaining 93 VIPs<sub>direct</sub>. On top of the bar is the number of VIPs<sub>direct</sub> that are also hub proteins (R6 or R7) in the host PPI network of liver cell surface proteins.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Statistical significance of overlaps between protein/gene sets.</title>
<p><bold>(A)</bold> The overlap between all VIPs and proteins in PHISTO. <bold>(B)</bold> The overlap between all VIPs and proteins in EHCO. <bold>(C)</bold> The overlap between the VIPs in the six main groups of HCV-targeted complexes and the R6 proteins. <bold>(D)</bold> The overlap between VIPs in the six main groups of HCV-targeted complexes and proteins in PHISTO. <bold>(E)</bold> The overlap between VIPs in the six main groups of HCV-targeted complexes and proteins in EHCO. <bold>(F)</bold> The overlap between VIPs in the six main groups of HCV-targeted complexes and known HCV entry factors. The background for panels A, B, D, and E is for all hepatocyte surface proteins and the background for panels C and F is for all VIPs.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Statistical significance of overlaps between sets of PPIs (network edges).</title>
<p><bold>(A)</bold> The overlap between HCV-VIPs<sub>direct</sub> PPIs and PPIs in PHISTO that were determined as direct based on their experimental methods (see <xref ref-type="supplementary-material" rid="pcbi.1005368.s014">S4 Table</xref>). <bold>(B)</bold> The overlap between HCV-VIPs<sub>indirect</sub> PPIs and PPIs in PHISTO that could not be determined as direct. Note that in PHISTO, other than core, NS3-4A and NS5A, the identity of the individual HCV protein(s) involving in the interaction with host proteins is not known; consequently, HCV was considered as a single node in the PPI network from PHISTO, and, therefore, the number of virus-host PPIs (i.e. network edges) is the same as that of the host proteins in this enrichment test.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Four known entry factors (white nodes) of HCV infection not identified in this work.</title>
<p><bold>(A)</bold> CLDN1; <bold>(B)</bold> SCARB1; <bold>(C)</bold> CD209; <bold>(D)</bold> NPC1L1. Blue nodes are VIPs<sub>indirect</sub>; gray nodes are not VIPs. The connections between the nodes represent physical interactions extracted from HIPPIE [<xref ref-type="bibr" rid="pcbi.1005368.ref014">14</xref>].</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s005" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>The ROC performance against known HCV entry factors of the <italic>in silico</italic> predictions and Li et al.’s siRNA experiment.</title>
<p>As described in the main text, using a cutoff of at least 70% sequence conservation to find SLiMs (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1A</xref>), we identified 15 of the 19 known HCV entry factors before complex analysis and 9 after, and Li et al. [<xref ref-type="bibr" rid="pcbi.1005368.ref005">5</xref>] identified 8 (see <xref ref-type="table" rid="pcbi.1005368.t001">Table 1</xref>). In all, the <italic>in silico</italic> method identified 899 (231 after complex analysis), and Li et al.’s experiment 45, hepatocyte surface proteins as potential HCV entry factors. In this figure, the cutoff of HCV E1/E2 sequence conservation was varied from 0% to 100%, at which the same procedure as described in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1</xref> was carried out, and sensitivity and specificity for the resulting predictions were calculated to generate the ROC curves, on which the performance obtained at 70% sequence conservation cutoff is indicated. AUC: Area Under Curve.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s006" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>Grouping of HCV-targeted protein complexes.</title>
<p>Using GAP [<xref ref-type="bibr" rid="pcbi.1005368.ref084">84</xref>], 190 HCV-targeted protein complexes (containing 258 VIPs) were hierarchically clustered based on the number of shared subunits. The threshold (Cut, bottom right) for the clustering is indicated. The six main clusters (groups) are boxed and labeled A-F. Within these six groups there are 231 VIPs. *Complex ID refers to notations in <xref ref-type="supplementary-material" rid="pcbi.1005368.s015">S5 Table</xref>, where detailed information of the HCV-targeted complexes is provided.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s007" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>VIPs versus randomly selected proteins found in protein complexes.</title>
<p>The distribution plot illustrates 100,000 randomly sampled sets, each consisting of 899 proteins (the same number as VIPs) sampled from the set of 2,456 human hepatocyte surface proteins (<xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1B</xref>). Each set was searched for protein complexes, which were required to contain at least three sampled proteins as indicated in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1D</xref>. The number of proteins retained in their targeted complexes in each sampling was counted as “number of sampled proteins in complexes”. The observed number (i.e., 258, indicated by dotted line) is the number of the VIPs found in the 190 HCV-targeted protein complexes.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s008" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s008" xlink:type="simple">
<label>S8 Fig</label>
<caption>
<title>Statistical significance of the three main enriched functionalities of HCV E1/E2-derived VIPs compared to those containing a binding domain for any SLiM in the ELM database.</title>
<p>The distribution plots for the functionality of <bold>(A)</bold> <italic>entry</italic>, <bold>(B)</bold> <italic>carcinogenesis</italic>, and <bold>(C)</bold> <italic>infectious disease</italic> were derived from results of 10,000 randomly sampled sets of proteins. In each set, 899 proteins (the same number as VIPs) were randomly sampled from a set of 1,320 proteins, which is the number of proteins containing a binding domain for any SLiM in the ELM database (348 proteins) and their first PPI neighbors (972 proteins) in the human PPI network of liver cell surface proteins. The same procedure as described in <xref ref-type="fig" rid="pcbi.1005368.g001">Fig 1D</xref> (see <xref ref-type="sec" rid="sec011">Methods</xref>) for protein complex and KEGG pathway analyses was carried out for each sample set. The number of enriched KEGG pathways in functionality of <italic>entry</italic>, <italic>carcinogenesis</italic>, and <italic>infectious disease</italic>, was counted respectively. The observed number (indicated by dotted line) is the number of KEGG pathways belonging to the given functionality enriched in the set of VIPs found in the six main groups of HCV-targeted protein complexes (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>).</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s009" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s009" xlink:type="simple">
<label>S9 Fig</label>
<caption>
<title>Statistical significance of SLiM-containing AVPs.</title>
<p><bold>(A)</bold> Of the 73 AVPs that were tested for entry-related anti-HCV activities in AVPdb, 29 harbor an HCV E1/E2 SLiM (one of nine) that can bind to VIPs found in the six main groups of HCV-targeted protein complexes (<xref ref-type="fig" rid="pcbi.1005368.g004">Fig 4</xref>); here, the number of AVPs containing at least one of the nine SLiMs for all sample sets, each consisting of 73 AVPs randomly sampled from a pool of 2059 AVPs (the total number of AVPs in AVPdb), was counted. <bold>(B)</bold> In this test, the sampling pool was the set of the 431 AVPs found to contain LIG_SH2_STAT5 and/or LIG_SH3_3 in AVPdb; the sample size was 23, of which those shown to be effective in inhibiting HCV entry in AVPdb were counted. <bold>(C)</bold> In this test, the sampling pool was the set of the 154 AVPs found to contain MOD_ProDKin_1 in AVPdb; the sample size was 7, of which those shown to be effective in inhibiting HCV entry in AVPdb were counted. For (A), (B) and (C), the statistics was calculated based on 10,000 sample sets.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s010" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s010" xlink:type="simple">
<label>S10 Fig</label>
<caption>
<title>The number of conserved (in ≥ 70% sequences) SLiMs found in HCV component proteins and protein length.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s011" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s011" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>GO terms enriched in the virus-host PPI network modules and representative functions according to Revigo.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s012" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s012" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Representative function(s) and supporting published experimental data for HCV-human PPI network modules 1–7.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s013" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s013" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Published experimental evidence for relations between SLiMs and R6 proteins and between R6 proteins and module functions in <xref ref-type="fig" rid="pcbi.1005368.g003">Fig 3</xref>.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s014" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s014" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Types of PPIs between HCV polyprotein and human protein in PHISTO and their detection methods.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s015" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s015" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>HCV-targeted protein complexes.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s016" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s016" xlink:type="simple">
<label>S6 Table</label>
<caption>
<title>KEGG pathways enriched in the six main protein complex groups.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pcbi.1005368.s017" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1005368.s017" xlink:type="simple">
<label>S1 Appendix</label>
<caption>
<title>Main functionalities associated with KEGG pathways enriched in the HCV-targeted protein complexes.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Drs Yi-Ling Lin, Mi-Hua Tao, and Wei-Chung Liu for careful reading of the manuscript and helpful suggestions.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1005368.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Chassey</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Meyniel-Schicklin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Aublin-Gex</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>André</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lotteau</surname> <given-names>V</given-names></name>. <article-title>New horizons for antiviral drug discovery from virus-host protein interaction networks</article-title>. <source>Current opinion in virology</source>. <year>2012</year>;<volume>2</volume>(<issue>5</issue>):<fpage>606</fpage>–<lpage>613</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.coviro.2012.09.001" xlink:type="simple">10.1016/j.coviro.2012.09.001</ext-link></comment> <object-id pub-id-type="pmid">23025912</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Chassey</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Meyniel-Schicklin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Vonderscher</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>André</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lotteau</surname> <given-names>V</given-names></name>. <article-title>Virus-host interactomics: new insights and opportunities for antiviral drug discovery</article-title>. <source>Genome Medicine</source>. <year>2014</year>;<volume>6</volume>:<fpage>115</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s13073-014-0115-1" xlink:type="simple">10.1186/s13073-014-0115-1</ext-link></comment> <object-id pub-id-type="pmid">25593595</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Christ</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Voet</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Marchand</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nicolet</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Desimmie</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Marchand</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication</article-title>. <source>Nat Chem Biol</source>. <year>2010</year>;<volume>6</volume>(<issue>6</issue>):<fpage>442</fpage>–<lpage>448</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nchembio.370" xlink:type="simple">10.1038/nchembio.370</ext-link></comment> <object-id pub-id-type="pmid">20473303</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Gates</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>XD</given-names></name>, <name name-style="western"><surname>Castle</surname> <given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>Genome-scale RNAi screen for host factors required for HIV replication</article-title>. <source>Cell Host Microbe</source>. <year>2008</year>;<volume>4</volume>(<issue>5</issue>):<fpage>495</fpage>–<lpage>504</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2008.10.004" xlink:type="simple">10.1016/j.chom.2008.10.004</ext-link></comment> <object-id pub-id-type="pmid">18976975</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y-Y</given-names></name>, <name name-style="western"><surname>Chiu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Lan</surname> <given-names>K-H</given-names></name>, <name name-style="western"><surname>Cha</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e1004163</fpage>. PubMed Central PMCID: PMC4095987. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1004163" xlink:type="simple">10.1371/journal.ppat.1004163</ext-link></comment> <object-id pub-id-type="pmid">24852294</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Deo</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Padi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Adelmant</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Calderwood</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Rolland</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins</article-title>. <source>Nature</source>. <year>2012</year>;<volume>487</volume>(<issue>7408</issue>):<fpage>491</fpage>–<lpage>495</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature11288" xlink:type="simple">10.1038/nature11288</ext-link></comment> <object-id pub-id-type="pmid">22810586</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alcami</surname> <given-names>A</given-names></name>. <article-title>Viral mimicry of cytokines, chemokines and their receptors</article-title>. <source>Nat Rev Immunol</source>. <year>2003</year>;<volume>3</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nri980" xlink:type="simple">10.1038/nri980</ext-link></comment> <object-id pub-id-type="pmid">12511874</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davey</surname> <given-names>NE</given-names></name>, <name name-style="western"><surname>Travé</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>TJ</given-names></name>. <article-title>How viruses hijack cell regulation</article-title>. <source>Trends Biochem Sci</source>. <year>2011</year>;<volume>36</volume>(<issue>3</issue>):<fpage>159</fpage>–<lpage>169</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tibs.2010.10.002" xlink:type="simple">10.1016/j.tibs.2010.10.002</ext-link></comment> <object-id pub-id-type="pmid">21146412</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garamszegi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Franzosa</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>Y</given-names></name>. <article-title>Signatures of Pleiotropy, Economy and Convergent Evolution in a Domain-Resolved Map of Human–Virus Protein–Protein Interaction Networks</article-title>. <source>PLoS Pathog</source>. <year>2013</year>;<volume>9</volume>(<issue>12</issue>):<fpage>e1003778</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003778" xlink:type="simple">10.1371/journal.ppat.1003778</ext-link></comment> <object-id pub-id-type="pmid">24339775</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hagai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Azia</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Babu</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Andino</surname> <given-names>R</given-names></name>. <article-title>Use of Host-like Peptide Motifs in Viral Proteins Is a Prevalent Strategy in Host-Virus Interactions</article-title>. <source>Cell Reports</source>. <year>2014</year>;<volume>7</volume>(<issue>5</issue>):<fpage>1729</fpage>–<lpage>1739</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2014.04.052" xlink:type="simple">10.1016/j.celrep.2014.04.052</ext-link></comment> <object-id pub-id-type="pmid">24882001</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dinkel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Michael</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Weatheritt</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Davey</surname> <given-names>NE</given-names></name>, <name name-style="western"><surname>Van Roey</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Altenberg</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>ELM—the database of eukaryotic linear motifs</article-title>. <source>Nucleic Acids Res</source>. <year>2011</year>;<volume>40</volume>(<issue>D1</issue>):<fpage>D242</fpage>–<lpage>251</lpage>. PubMed Central PMCID: PMC3245074.</mixed-citation></ref>
<ref id="pcbi.1005368.ref012"><label>12</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Lazarus</surname> <given-names>JV</given-names></name>, <name name-style="western"><surname>Harmon</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sperle</surname> <given-names>I</given-names></name>. <source>Global policy report on the prevention and control of viral hepatitis</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2013</year>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindenbach</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Rice</surname> <given-names>CM</given-names></name>. <article-title>The ins and outs of hepatitis C virus entry and assembly</article-title>. <source>Nat Rev Microbiol</source>. <year>2013</year>;<volume>11</volume>(<issue>10</issue>):<fpage>688</fpage>–<lpage>700</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro3098" xlink:type="simple">10.1038/nrmicro3098</ext-link></comment> <object-id pub-id-type="pmid">24018384</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schaefer</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Fontaine</surname> <given-names>J-F</given-names></name>, <name name-style="western"><surname>Vinayagam</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Porras</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wanker</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Andrade-Navarro</surname> <given-names>MA</given-names></name>. <article-title>HIPPIE: Integrating protein interaction networks with experiment based quality scores</article-title>. <source>PloS one</source>. <year>2012</year>;<volume>7</volume>(<issue>2</issue>):<fpage>e31826</fpage>. PubMed Central PMCID: PMC3279424. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0031826" xlink:type="simple">10.1371/journal.pone.0031826</ext-link></comment> <object-id pub-id-type="pmid">22348130</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>C-N</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>J-M</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>C-H</given-names></name>, <name name-style="western"><surname>Tseng</surname> <given-names>H-H</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>C-Y</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>K-T</given-names></name>, <etal>et al</etal>. <article-title>Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online)</article-title>. <source>BMC Bioinformatics</source>. <year>2007</year>;<volume>8</volume>(<issue>1</issue>):<fpage>66</fpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tekir</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Çakır</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ardıç</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sayılırbaş</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Konuk</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Konuk</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>PHISTO: pathogen-host interaction search tool</article-title>. <source>Bioinformatics</source>. <year>2013</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1357</fpage>–<lpage>1358</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btt137" xlink:type="simple">10.1093/bioinformatics/btt137</ext-link></comment> <object-id pub-id-type="pmid">23515528</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barabási</surname> <given-names>A-L</given-names></name>, <name name-style="western"><surname>Oltvai</surname> <given-names>ZN</given-names></name>. <article-title>Network biology: understanding the cell's functional organization</article-title>. <source>Nature Reviews Genetics</source>. <year>2004</year>;<volume>5</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>113</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrg1272" xlink:type="simple">10.1038/nrg1272</ext-link></comment> <object-id pub-id-type="pmid">14735121</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guimerà</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nunes</surname> <given-names>Amaral LA</given-names></name>. <article-title>Functional cartography of complex metabolic networks</article-title>. <source>Nature</source>. <year>2005</year>;<volume>433</volume>(<issue>7028</issue>):<fpage>895</fpage>–<lpage>900</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature03288" xlink:type="simple">10.1038/nature03288</ext-link></comment> <object-id pub-id-type="pmid">15729348</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dyer</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Murali</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Sobral</surname> <given-names>BW</given-names></name>. <article-title>The Landscape of Human Proteins Interacting with Viruses and Other Pathogens</article-title>. <source>PLoS Pathog</source>. <year>2008</year>;<volume>4</volume>(<issue>2</issue>):<fpage>e32</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.0040032" xlink:type="simple">10.1371/journal.ppat.0040032</ext-link></comment> <object-id pub-id-type="pmid">18282095</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashburner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ball</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Blake</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Botstein</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Butler</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cherry</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Gene Ontology: tool for the unification of biology</article-title>. <source>Nat Genet</source>. <year>2000</year>;<volume>25</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/75556" xlink:type="simple">10.1038/75556</ext-link></comment> <object-id pub-id-type="pmid">10802651</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Supek</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Bošnjak</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Škunca</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Šmuc</surname> <given-names>T</given-names></name>. <article-title>REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e21800</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0021800" xlink:type="simple">10.1371/journal.pone.0021800</ext-link></comment> <object-id pub-id-type="pmid">21789182</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brazzoli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bianchi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Filippini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Weiner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Pizza</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes</article-title>. <source>J Virol</source>. <year>2008</year>;<volume>82</volume>(<issue>17</issue>):<fpage>8316</fpage>–<lpage>8329</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.00665-08" xlink:type="simple">10.1128/JVI.00665-08</ext-link></comment> <object-id pub-id-type="pmid">18579606</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Tian</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Machida</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>MMC</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Foung</surname> <given-names>SKH</given-names></name>, <etal>et al</etal>. <article-title>Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>50</issue>):<fpage>41922</fpage>–<lpage>41930</lpage>. PubMed Central PMCID: PMC3516739. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M112.414789" xlink:type="simple">10.1074/jbc.M112.414789</ext-link></comment> <object-id pub-id-type="pmid">23095753</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yeatman</surname> <given-names>TJ</given-names></name>. <article-title>A renaissance for SRC</article-title>. <source>Nat Rev Cancer</source>. <year>2004</year>;<volume>4</volume>(<issue>6</issue>):<fpage>470</fpage>–<lpage>480</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrc1366" xlink:type="simple">10.1038/nrc1366</ext-link></comment> <object-id pub-id-type="pmid">15170449</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Panjarian</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Iacob</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Engen</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Smithgall</surname> <given-names>TE</given-names></name>. <article-title>Structure and Dynamic Regulation of Abl Kinases</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>8</issue>):<fpage>5443</fpage>–<lpage>5450</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.R112.438382" xlink:type="simple">10.1074/jbc.R112.438382</ext-link></comment> <object-id pub-id-type="pmid">23316053</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlier</surname> <given-names>M-F</given-names></name>, <name name-style="western"><surname>Nioche</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Broutin-L'Hermite</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Boujemaa</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Clainche</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Egile</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>GRB2 links signaling to actin assembly by enhancing interaction of neural wiskott-aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>29</issue>):<fpage>21946</fpage>–<lpage>21952</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M000687200" xlink:type="simple">10.1074/jbc.M000687200</ext-link></comment> <object-id pub-id-type="pmid">10781580</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chaki</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Rivera</surname> <given-names>GM</given-names></name>. <article-title>Integration of signaling and cytoskeletal remodeling by Nck in directional cell migration</article-title>. <source>BioArchitecture</source>. <year>2013</year>;<volume>3</volume>(<issue>3</issue>):<fpage>57</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4161/bioa.25744" xlink:type="simple">10.4161/bioa.25744</ext-link></comment> <object-id pub-id-type="pmid">23887203</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cosen-Binker</surname> <given-names>LI</given-names></name>, <name name-style="western"><surname>Kapus</surname> <given-names>A</given-names></name>. <article-title>Cortactin: The Gray Eminence of the Cytoskeleton</article-title>. <source>Physiology</source>. <year>2006</year>;<volume>21</volume>(<issue>5</issue>):<fpage>352</fpage>–<lpage>361</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ke</surname> <given-names>P-Y</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>SS-L</given-names></name>. <article-title>Hepatitis C Virus and Cellular Stress Response: Implications to Molecular Pathogenesis of Liver Diseases</article-title>. <source>Viruses</source>. <year>2012</year>;<volume>4</volume>(<issue>10</issue>):<fpage>2251</fpage>–<lpage>2290</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/v4102251" xlink:type="simple">10.3390/v4102251</ext-link></comment> <object-id pub-id-type="pmid">23202463</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Seol</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>E2 of hepatitis C virus inhibits apoptosis</article-title>. <source>J Immunol</source>. <year>2005</year>;<volume>175</volume>(<issue>12</issue>):<fpage>8226</fpage>–<lpage>8235</lpage>. <object-id pub-id-type="pmid">16339562</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ouyang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bao</surname> <given-names>S</given-names></name>. <article-title>The activation of Akt/PKB signaling pathway and cell survival</article-title>. <source>Journal of Cellular and Molecular Medicine</source>. <year>2005</year>;<volume>9</volume>(<issue>1</issue>):<fpage>59</fpage>–<lpage>71</lpage>. <object-id pub-id-type="pmid">15784165</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Luo</surname> <given-names>J-L</given-names></name>, <name name-style="western"><surname>Kamata</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Karin</surname> <given-names>M</given-names></name>. <article-title>IKK/NF-kappaB signaling: balancing life and death—a new approach to cancer therapy</article-title>. <source>The Journal of clinical investigation</source>. <year>2005</year>;<volume>115</volume>(<issue>10</issue>):<fpage>2625</fpage>–<lpage>2632</lpage>. PubMed Central PMCID: PMC1236696. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI26322" xlink:type="simple">10.1172/JCI26322</ext-link></comment> <object-id pub-id-type="pmid">16200195</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Pène</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Krishnamurthy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Cha</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>TJ</given-names></name>. <article-title>Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly</article-title>. <source>Nat Med</source>. <year>2013</year>;<volume>19</volume>(<issue>6</issue>):<fpage>722</fpage>–<lpage>729</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm.3190" xlink:type="simple">10.1038/nm.3190</ext-link></comment> <object-id pub-id-type="pmid">23708292</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michie</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Nakagawa</surname> <given-names>R</given-names></name>. <article-title>The link between PKC alpha regulation and cellular transformation</article-title>. <source>Immunol Lett</source>. <year>2005</year>;<volume>96</volume>(<issue>2</issue>):<fpage>155</fpage>–<lpage>162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.imlet.2004.08.013" xlink:type="simple">10.1016/j.imlet.2004.08.013</ext-link></comment> <object-id pub-id-type="pmid">15585319</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fimia</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Evangelisti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Alonzi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Romani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fratini</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Paonessa</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Conventional Protein Kinase C Inhibition Prevents Alpha Interferon-Mediated Hepatitis C Virus Replicon Clearance by Impairing STAT Activation</article-title>. <source>J Virol</source>. <year>2004</year>;<volume>78</volume>(<issue>23</issue>):<fpage>12809</fpage>–<lpage>12816</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.78.23.12809-12816.2004" xlink:type="simple">10.1128/JVI.78.23.12809-12816.2004</ext-link></comment> <object-id pub-id-type="pmid">15542633</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Guglielmo</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Le Roy</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Goodfellow</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Wrana</surname> <given-names>JL</given-names></name>. <article-title>Distinct endocytic pathways regulate TGF-β receptor signalling and turnover</article-title>. <source>Nature Cell Biology</source>. <year>2003</year>;<volume>5</volume>(<issue>5</issue>):<fpage>410</fpage>–<lpage>421</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncb975" xlink:type="simple">10.1038/ncb975</ext-link></comment> <object-id pub-id-type="pmid">12717440</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>S-H</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>SB</given-names></name>. <article-title>Modulation of the Transforming Growth Factor-β Signal Transduction Pathway by Hepatitis C Virus Nonstructural 5A Protein</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>11</issue>):<fpage>7468</fpage>–<lpage>7478</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M512438200" xlink:type="simple">10.1074/jbc.M512438200</ext-link></comment> <object-id pub-id-type="pmid">16407286</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reyland</surname> <given-names>ME</given-names></name>. <article-title>Protein kinase Cδ and apoptosis</article-title>. <source>Biochemical Society Transactions</source>. <year>2007</year>;<volume>35</volume>(<issue>5</issue>):<fpage>1001</fpage>–<lpage>1004</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zona</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lupberger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sidahmed-Adrar</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Thumann</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Barnes</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex</article-title>. <source>Cell Host Microbe</source>. <year>2013</year>;<volume>13</volume>(<issue>3</issue>):<fpage>302</fpage>–<lpage>313</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2013.02.006" xlink:type="simple">10.1016/j.chom.2013.02.006</ext-link></comment> <object-id pub-id-type="pmid">23498955</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whittaker</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Marais</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>AX</given-names></name>. <article-title>The role of signaling pathways in the development and treatment of hepatocellular carcinoma</article-title>. <source>Oncogene</source>. <year>2010</year>;<volume>29</volume>(<issue>36</issue>):<fpage>4989</fpage>–<lpage>5005</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/onc.2010.236" xlink:type="simple">10.1038/onc.2010.236</ext-link></comment> <object-id pub-id-type="pmid">20639898</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miled</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hon</surname> <given-names>W-C</given-names></name>, <name name-style="western"><surname>Perisic</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Zvelebil</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Inbar</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit</article-title>. <source>Science</source>. <year>2007</year>;<volume>317</volume>(<issue>5835</issue>):<fpage>239</fpage>–<lpage>242</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1135394" xlink:type="simple">10.1126/science.1135394</ext-link></comment> <object-id pub-id-type="pmid">17626883</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Downward</surname> <given-names>J</given-names></name>. <article-title>The GRB2/Sem-5 adaptor protein</article-title>. <source>FEBS Letters</source>. <year>1994</year>;<volume>338</volume>(<issue>2</issue>):<fpage>113</fpage>–<lpage>117</lpage>. <object-id pub-id-type="pmid">8307166</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ravichandran</surname> <given-names>KS</given-names></name>. <article-title>Signaling via Shc family adapter proteins</article-title>. <source>Oncogene</source>. <year>2001</year>;<volume>20</volume>(<issue>44</issue>):<fpage>6322</fpage>–<lpage>6330</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.onc.1204776" xlink:type="simple">10.1038/sj.onc.1204776</ext-link></comment> <object-id pub-id-type="pmid">11607835</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>L-J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ren</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ke</surname> <given-names>J-S</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors</article-title>. <source>Experimental Cell Research</source>. <year>2005</year>;<volume>305</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.yexcr.2004.12.024" xlink:type="simple">10.1016/j.yexcr.2004.12.024</ext-link></comment> <object-id pub-id-type="pmid">15777784</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naas</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ghorbani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Alvarez-Maya</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Lapner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kothary</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>De Repentigny</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2</article-title>. <source>J Gen Virol</source>. <year>2005</year>;<volume>86</volume>(<issue>8</issue>):<fpage>2185</fpage>–<lpage>2196</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Keshava Prasad</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Goel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kandasamy</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Keerthikumar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mathivanan</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Human Protein Reference Database—2009 update</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>;<volume>37</volume>(<issue>suppl 1</issue>):<fpage>D767</fpage>–<lpage>D772</lpage>. PubMed Central PMCID: PMC2686490.</mixed-citation></ref>
<ref id="pcbi.1005368.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kandasamy</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Keerthikumar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Goel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mathivanan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Patankar</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Shafreen</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Human Proteinpedia: a unified discovery resource for proteomics research</article-title>. <source>Nucleic Acids Res</source>. <year>2009</year>;<volume>37</volume>(<issue>suppl 1</issue>):<fpage>D773</fpage>–<lpage>D781</lpage>. PubMed Central PMCID: PMC2686511.</mixed-citation></ref>
<ref id="pcbi.1005368.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ploss</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Gaysinskaya</surname> <given-names>VA</given-names></name>, <name name-style="western"><surname>Panis</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>You</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>de Jong</surname> <given-names>YP</given-names></name>, <etal>et al</etal>. <article-title>Human occludin is a hepatitis C virus entry factor required for infection of mouse cells</article-title>. <source>Nature</source>. <year>2009</year>;<volume>457</volume>(<issue>7231</issue>):<fpage>882</fpage>–<lpage>886</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature07684" xlink:type="simple">10.1038/nature07684</ext-link></comment> <object-id pub-id-type="pmid">19182773</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dorner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Donovan</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Labitt</surname> <given-names>RN</given-names></name>, <name name-style="western"><surname>Budell</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Friling</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Completion of the entire hepatitis C virus life cycle in genetically humanized mice</article-title>. <source>Nature</source>. <year>2013</year>;<volume>501</volume>(<issue>7466</issue>):<fpage>237</fpage>–<lpage>241</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature12427" xlink:type="simple">10.1038/nature12427</ext-link></comment> <object-id pub-id-type="pmid">23903655</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pileri</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Uematsu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Campagnoli</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Galli</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Falugi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Petracca</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Binding of Hepatitis C Virus to CD81</article-title>. <source>Science</source>. <year>1998</year>;<volume>282</volume>(<issue>5390</issue>):<fpage>938</fpage>–<lpage>941</lpage>. <object-id pub-id-type="pmid">9794763</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Giang</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nieusma</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kadam</surname> <given-names>RU</given-names></name>, <name name-style="western"><surname>Cogburn</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Hua</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis C Virus E2 Envelope Glycoprotein Core Structure</article-title>. <source>Science</source>. <year>2013</year>;<volume>342</volume>(<issue>6162</issue>):<fpage>1090</fpage>–<lpage>1094</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1243876" xlink:type="simple">10.1126/science.1243876</ext-link></comment> <object-id pub-id-type="pmid">24288331</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fawcett</surname> <given-names>T</given-names></name>. <article-title>An introduction to ROC analysis</article-title>. <source>Pattern recognition letters</source>. <year>2006</year>;<volume>27</volume>(<issue>8</issue>):<fpage>861</fpage>–<lpage>874</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Brass</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Ng</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Xavier</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>TJ</given-names></name>, <etal>et al</etal>. <article-title>A genome-wide genetic screen for host factors required for hepatitis C virus propagation</article-title>. <source>PNAS</source>. <year>2009</year>;<volume>106</volume>(<issue>38</issue>):<fpage>16410</fpage>–<lpage>16415</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0907439106" xlink:type="simple">10.1073/pnas.0907439106</ext-link></comment> <object-id pub-id-type="pmid">19717417</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname> <given-names>Zoe H</given-names></name>, <name name-style="western"><surname>Verschueren</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Jang</surname> <given-names>Gwendolyn M</given-names></name>, <name name-style="western"><surname>Kleffman</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>Jeffrey R</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Global Mapping of Herpesvirus-Host Protein Complexes Reveals a Transcription Strategy for Late Genes</article-title>. <source>Molecular Cell</source>. <year>2015</year>;<volume>57</volume>(<issue>2</issue>):<fpage>349</fpage>–<lpage>360</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molcel.2014.11.026" xlink:type="simple">10.1016/j.molcel.2014.11.026</ext-link></comment> <object-id pub-id-type="pmid">25544563</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruepp</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Waegele</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Lechner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Brauner</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Dunger-Kaltenbach</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Fobo</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>CORUM: the comprehensive resource of mammalian protein complexes—2009</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>38</volume>(<issue>suppl 1</issue>):<fpage>D497</fpage>–<lpage>D501</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qureshi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Thakur</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Tandon</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>M</given-names></name>. <article-title>AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>(<issue>D1</issue>):<fpage>D1147</fpage>–<lpage>D1153</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zona</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tawar</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Zeisel</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Schuster</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lupberger</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>CD81-Receptor Associations—Impact for Hepatitis C Virus Entry and Antiviral Therapies</article-title>. <source>Viruses</source>. <year>2014</year>;<volume>6</volume>(<issue>2</issue>):<fpage>875</fpage>–<lpage>892</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3390/v6020875" xlink:type="simple">10.3390/v6020875</ext-link></comment> <object-id pub-id-type="pmid">24553110</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Massagué</surname> <given-names>J</given-names></name>. <article-title>TGFβ signalling in context</article-title>. <source>Nature Reviews Molecular Cell Biology</source>. <year>2012</year>;<volume>13</volume>(<issue>10</issue>):<fpage>616</fpage>–<lpage>630</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrm3434" xlink:type="simple">10.1038/nrm3434</ext-link></comment> <object-id pub-id-type="pmid">22992590</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>M</given-names></name>. <article-title>The Par3/Par6/aPKC complex and epithelial cell polarity</article-title>. <source>Experimental Cell Research</source>. <year>2013</year>;<volume>319</volume>(<issue>10</issue>):<fpage>1357</fpage>–<lpage>1364</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.yexcr.2013.03.021" xlink:type="simple">10.1016/j.yexcr.2013.03.021</ext-link></comment> <object-id pub-id-type="pmid">23535009</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eksioglu</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bayouth</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Bess</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>H-y</given-names></name>, <name name-style="western"><surname>Nelson</surname> <given-names>DR</given-names></name>, <etal>et al</etal>. <article-title>Characterization of HCV Interactions with Toll-Like Receptors and RIG-I in Liver Cells</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e21186</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0021186" xlink:type="simple">10.1371/journal.pone.0021186</ext-link></comment> <object-id pub-id-type="pmid">21695051</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jamma</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hussain</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lau</surname> <given-names>DTY</given-names></name>. <article-title>Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony</article-title>. <source>Curr Hepat Rep</source>. <year>2010</year>;<volume>9</volume>(<issue>4</issue>):<fpage>260</fpage>–<lpage>269</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11901-010-0060-4" xlink:type="simple">10.1007/s11901-010-0060-4</ext-link></comment> <object-id pub-id-type="pmid">21258658</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hernáez</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tarragó</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Giralt</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Escribano</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Alonso</surname> <given-names>C</given-names></name>. <article-title>Small Peptide Inhibitors Disrupt a High-Affinity Interaction between Cytoplasmic Dynein and a Viral Cargo Protein</article-title>. <source>J Virol</source>. <year>2010</year>;<volume>84</volume>(<issue>20</issue>):<fpage>10792</fpage>–<lpage>10801</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.01168-10" xlink:type="simple">10.1128/JVI.01168-10</ext-link></comment> <object-id pub-id-type="pmid">20686048</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chertov</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Oppenheim</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Lubkowski</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>McGrath</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture</article-title>. <source>PloS one</source>. <year>2011</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e14474</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0014474" xlink:type="simple">10.1371/journal.pone.0014474</ext-link></comment> <object-id pub-id-type="pmid">21264298</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuan</surname> <given-names>Z-q</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kaneko</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sussman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bokoch</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Kruh</surname> <given-names>GD</given-names></name>, <etal>et al</etal>. <article-title>ArgBP2γ Interacts with Akt and p21-activated Kinase-1 and Promotes Cell Survival</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>22</issue>):<fpage>21483</fpage>–<lpage>21490</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M500097200" xlink:type="simple">10.1074/jbc.M500097200</ext-link></comment> <object-id pub-id-type="pmid">15784622</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fabregat</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Roncero</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fernández</surname> <given-names>M</given-names></name>. <article-title>Survival and apoptosis: a dysregulated balance in liver cancer</article-title>. <source>Liver International</source>. <year>2007</year>;<volume>27</volume>(<issue>2</issue>):<fpage>155</fpage>–<lpage>162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1478-3231.2006.01409.x" xlink:type="simple">10.1111/j.1478-3231.2006.01409.x</ext-link></comment> <object-id pub-id-type="pmid">17311609</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Durmuş</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Çakır</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Özgür</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Guthke</surname> <given-names>R</given-names></name>. <article-title>A review on computational systems biology of pathogen–host interactions</article-title>. <source>Front Microbiol</source>. <year>2015</year>:<volume>235</volume>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thieu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Joshi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Warren</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Korkin</surname> <given-names>D</given-names></name>. <article-title>Literature mining of host–pathogen interactions: comparing feature-based supervised learning and language-based approaches</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>(<issue>6</issue>):<fpage>867</fpage>–<lpage>875</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/bts042" xlink:type="simple">10.1093/bioinformatics/bts042</ext-link></comment> <object-id pub-id-type="pmid">22285561</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eckardt-Michel</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lorek</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baxmann</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Grunwald</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Keil</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Zimmer</surname> <given-names>G</given-names></name>. <article-title>The Fusion Protein of Respiratory Syncytial Virus Triggers p53-Dependent Apoptosis</article-title>. <source>J Virol</source>. <year>2008</year>;<volume>82</volume>(<issue>7</issue>):<fpage>3236</fpage>–<lpage>3249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.01887-07" xlink:type="simple">10.1128/JVI.01887-07</ext-link></comment> <object-id pub-id-type="pmid">18216092</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pahl</surname> <given-names>HL</given-names></name>, <name name-style="western"><surname>Baeuerle</surname> <given-names>PA</given-names></name>. <article-title>Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B</article-title>. <source>J Virol</source>. <year>1995</year>;<volume>69</volume>(<issue>3</issue>):<fpage>1480</fpage>–<lpage>1484</lpage>. <object-id pub-id-type="pmid">7853480</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ray</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Basu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Steele</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Beyene</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>McHowat</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Meyer</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells</article-title>. <source>Virology</source>. <year>2004</year>;<volume>321</volume>(<issue>2</issue>):<fpage>181</fpage>–<lpage>188</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.virol.2003.12.014" xlink:type="simple">10.1016/j.virol.2003.12.014</ext-link></comment> <object-id pub-id-type="pmid">15051379</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Evans</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dampier</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ungar</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tozeren</surname> <given-names>A</given-names></name>. <article-title>Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs</article-title>. <source>BMC Medical Genomics</source>. <year>2009</year>;<volume>2</volume>:<fpage>27</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1755-8794-2-27" xlink:type="simple">10.1186/1755-8794-2-27</ext-link></comment> <object-id pub-id-type="pmid">19450270</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferenci</surname> <given-names>P</given-names></name>. <article-title>Treatment of hepatitis C in difficult-to-treat patients</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>. <year>2015</year>;<volume>12</volume>(<issue>5</issue>):<fpage>284</fpage>–<lpage>292</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrgastro.2015.53" xlink:type="simple">10.1038/nrgastro.2015.53</ext-link></comment> <object-id pub-id-type="pmid">25895822</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Fofana</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Heydmann</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Barth</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Soulier</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Habersetzer</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e1004128</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1004128" xlink:type="simple">10.1371/journal.ppat.1004128</ext-link></comment> <object-id pub-id-type="pmid">24830295</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zahid</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Turek</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Thi</surname> <given-names>VLD</given-names></name>, <name name-style="western"><surname>Guérin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fofana</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination</article-title>. <source>Hepatology (Baltimore, Md)</source>. <year>2013</year>;<volume>57</volume>(<issue>2</issue>):<fpage>492</fpage>–<lpage>504</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fofana</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Thumann</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Turek</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zona</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tawar</surname> <given-names>RG</given-names></name>, <etal>et al</etal>. <article-title>A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>(<issue>5</issue>):<fpage>e64221</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0064221" xlink:type="simple">10.1371/journal.pone.0064221</ext-link></comment> <object-id pub-id-type="pmid">23704981</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lupberger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zeisel</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Thumann</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fofana</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Zona</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy</article-title>. <source>Nat Med</source>. <year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>589</fpage>–<lpage>595</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm.2341" xlink:type="simple">10.1038/nm.2341</ext-link></comment> <object-id pub-id-type="pmid">21516087</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Catanese</surname> <given-names>MT</given-names></name>, <name name-style="western"><surname>Law</surname> <given-names>LMJ</given-names></name>, <name name-style="western"><surname>Khetani</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Syder</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Ploss</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system</article-title>. <source>Nature biotechnology</source>. <year>2010</year>;<volume>28</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>171</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nbt.1604" xlink:type="simple">10.1038/nbt.1604</ext-link></comment> <object-id pub-id-type="pmid">20118917</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Timpe</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Stamataki</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Jennings</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Farquhar</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>HJ</given-names></name>, <etal>et al</etal>. <article-title>Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies</article-title>. <source>Hepatology</source>. <year>2008</year>;<volume>47</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.21959" xlink:type="simple">10.1002/hep.21959</ext-link></comment> <object-id pub-id-type="pmid">17941058</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witteveldt</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Bitzegeio</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koutsoudakis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Owsianka</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Angus</surname> <given-names>AGN</given-names></name>, <etal>et al</etal>. <article-title>CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells</article-title>. <source>J Gen Virol</source>. <year>2009</year>;<volume>90</volume>(<issue>1</issue>):<fpage>48</fpage>–<lpage>58</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mothes</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Sherer</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhong</surname> <given-names>P</given-names></name>. <article-title>Virus Cell-to-Cell Transmission</article-title>. <source>J Virol</source>. <year>2010</year>;<volume>84</volume>(<issue>17</issue>):<fpage>8360</fpage>–<lpage>8368</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JVI.00443-10" xlink:type="simple">10.1128/JVI.00443-10</ext-link></comment> <object-id pub-id-type="pmid">20375157</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baugh</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Garcia-Rivera</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Gallay</surname> <given-names>PA</given-names></name>. <article-title>Host-targeting agents in the treatment of hepatitis C: A beginning and an end?</article-title> <source>Antiviral Research</source>. <year>2013</year>;<volume>100</volume>(<issue>2</issue>):<fpage>555</fpage>–<lpage>561</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.antiviral.2013.09.020" xlink:type="simple">10.1016/j.antiviral.2013.09.020</ext-link></comment> <object-id pub-id-type="pmid">24091203</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>The UniProt Consortium</collab>. <article-title>UniProt: a hub for protein information</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>(<issue>D1</issue>):<fpage>D204</fpage>–<lpage>D212</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dennis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sherman</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hosack</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lane</surname> <given-names>HC</given-names></name>, <etal>et al</etal>. <article-title>DAVID: Database for Annotation, Visualization, and Integrated Discovery</article-title>. <source>Genome Biology</source>. <year>2003</year>;<volume>4</volume>(<issue>5</issue>):<fpage>P3</fpage>. <object-id pub-id-type="pmid">12734009</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>H-M</given-names></name>, <name name-style="western"><surname>Tien</surname> <given-names>Y-J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>C-h</given-names></name>. <article-title>GAP: A graphical environment for matrix visualization and cluster analysis</article-title>. <source>Computational Statistics &amp; Data Analysis</source>. <year>2010</year>;<volume>54</volume>(<issue>3</issue>):<fpage>767</fpage>–<lpage>778</lpage>.</mixed-citation></ref>
<ref id="pcbi.1005368.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanehisa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Goto</surname> <given-names>S</given-names></name>. <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source>Nucleic Acids Res</source>. <year>2000</year>;<volume>28</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>30</lpage>. <object-id pub-id-type="pmid">10592173</object-id></mixed-citation></ref>
<ref id="pcbi.1005368.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L-G</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>Q-Y</given-names></name>. <article-title>clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters</article-title>. <source>OMICS: A Journal of Integrative Biology</source>. <year>2012</year>;<volume>16</volume>(<issue>5</issue>):<fpage>284</fpage>–<lpage>287</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/omi.2011.0118" xlink:type="simple">10.1089/omi.2011.0118</ext-link></comment> <object-id pub-id-type="pmid">22455463</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>